WO2022155550A1 - Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide - Google Patents

Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide Download PDF

Info

Publication number
WO2022155550A1
WO2022155550A1 PCT/US2022/012640 US2022012640W WO2022155550A1 WO 2022155550 A1 WO2022155550 A1 WO 2022155550A1 US 2022012640 W US2022012640 W US 2022012640W WO 2022155550 A1 WO2022155550 A1 WO 2022155550A1
Authority
WO
WIPO (PCT)
Prior art keywords
lamp
reaction
biological sample
test
solid phase
Prior art date
Application number
PCT/US2022/012640
Other languages
English (en)
Inventor
Aaron Adler
Bryan BARTLEY
Mike GAVIN
Jordan SEVILLE
Darby MCCHESNEY
Frank M. Laduca
Fujr Osman IBRAHIM OSMAN
Mohit Verma
Original Assignee
Purdue Research Foundation
Raytheon BBN Technologies, Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation, Raytheon BBN Technologies, Corp. filed Critical Purdue Research Foundation
Priority to EP22704038.3A priority Critical patent/EP4278003A1/fr
Publication of WO2022155550A1 publication Critical patent/WO2022155550A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction

Definitions

  • PCR Polymerase chain reaction
  • Quantitative PCR is an adaptation of PCR which allows monitoring of the amplification of a targeted nucleotide. Diagnostic qPCR has been applied to detect nucleotides that are indicative of infectious diseases, cancer, and genetic abnormalities.
  • Reverse transcription PCR is an adaptation of qPCR which allows detection of a target RNA nucleotides. Because of this ability, RT-PCR is well-suited for detecting virus pathogens. However, RT-PCR uses sizeable equipment which may not be available in certain point of care settings. Additionally, RT-PCR uses trained personnel, significant sample preparation, and time to perform and obtain results.
  • LAMP Loop-Mediated Isothermal Amplification
  • RT-LAMP Reverse-transcription LAMP
  • RT-LAMP Reverse-transcription LAMP
  • the present disclosure is drawn to technologies (e.g., methods, systems, and assemblies) for use in detecting a target nucleotide using Loop-Mediated Isothermal Amplification (LAMP) on a solid phase medium.
  • LAMP Loop-Mediated Isothermal Amplification
  • the target nucleotide can be known to reside in a pathogen of interest.
  • the LAMP analysis can be a reverse transcription (RT) RT-LAMP analysis.
  • LAMP reaction assemblies can comprise a substantially hygroscopic agent free LAMP reagent mixture in combination with a solidphase reaction medium.
  • the solid-phase medium can be hydrophilic, absorbent, and porous.
  • the solid-phase medium can be substantially free of magnesium- interfering agents.
  • the magnesium-interfering agents can include magnesium-containing compounds and chelating agents that interfere with magnesium.
  • the solid-phase medium can be a cellulose-based medium.
  • the cellulose-based medium can have a surface area to thickness ratio between about 30 and about 600.
  • the cellulose-based medium can have a pore size of greater than about 1 micron and less than about 100 microns.
  • the solid-phase medium can comprise paper.
  • the solid-phase medium can comprise glassfiber.
  • the solid-phase medium can comprise nylon, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, or hydrophilic polytetrafluoroethylene (PTFE), or combinations thereof.
  • PTFE hydrophilic polytetrafluoroethylene
  • the LAMP reaction assembly can further comprise an adhesive substantially free of magnesium-interfering agents and hygroscopic agents.
  • the LAMP reaction assembly can further comprise a spreading layer that is less hydrophilic than the solid-phase reaction medium.
  • methods of manufacturing a LAMP reaction assembly as recited in the preceding can comprise combining the substantially hygroscopic agent free LAMP reagent mixture with the solid-phase reaction medium such that the reagent mixture is held in contact with the solid-phase reaction medium.
  • the method can comprise controlling discoloration using a nondiscoloration additive.
  • the non-discoloration additive can comprise a sugar, a buffer, a blocking agent, or combinations thereof.
  • the nondiscoloration additive can comprise a sugar comprising one or more of trehalose, glucose, sucrose, dextran, or combinations thereof.
  • the non-discoloration additive can comprise a blocking agent comprising bovine serum albumin, casein, or combinations thereof.
  • methods of performing a LAMP analysis can comprise providing a LAMP reaction assembly as recited in the preceding, applying a biological sample to the reaction assembly, heating the assembly to a temperature sufficient to initiate LAMP reaction, and maintaining the temperature for a time sufficient to complete the LAMP reaction.
  • the biological sample can be one or more of saliva, mucus, blood, urine, feces, sweat, exhaled breath condensate, or combinations thereof.
  • the biological sample can be saliva.
  • the method can further comprise detecting a viral pathogen.
  • the LAMP analysis can be reverse transcription LAMP (RT-LAMP).
  • a system for a chromatic LAMP analysis can comprise a substantially non-reactive solid phase reaction medium, and a non-interfering reagent mixture.
  • the substantially non-reactive solid phase reaction medium can be hydrophilic, absorbent, and porous.
  • the substantially non-reactive solid phase reaction medium can be substantially free of oxidizing agents, pH-interfering agents, or combinations thereof.
  • the substantially non-reactive solid phase reaction medium can have a buffering capacity from about 0.01 mM to about 5 mM.
  • the substantially non-reactive solid phase reaction medium has a maximum absorbance wavelength (Xmax) within a testing range when combined with a pH sensitive dye.
  • the substantially non-reactive solid phase reaction medium can comprise cellulose or glass fiber.
  • the system can further comprise an adhesive, a spreading layer, a spacer, a plastic carrier, or combinations thereof.
  • each of the adhesive, spreading layer, spacer, or plastic carrier can be substantially free of oxidizing agents and pH-interfering agents.
  • the non-interfering reagent mixture can further comprise one or more target primers, DNA polymerase, or a re-solubilization agent.
  • methods of maximizing accuracy of a chromatic output signal in a solid phase pH-dependent LAMP analysis can comprise providing a solid phase reaction medium that minimizes non-LAMP reaction produced discoloration, and performing the LAMP analysis on the solid phase reaction medium.
  • the method can comprise controlling non-LAMP produced discoloration from non-LAMP reaction produced protons.
  • the method can comprise controlling non- LAMP reaction produced discoloration using a non-discoloration additive.
  • the non-discoloration additive can comprise a sugar, a buffer, a blocking agent, or combinations thereof.
  • the non-discoloration additive can comprise a sugar comprising one or more of trehalose, glucose, sucrose, dextran, or combinations thereof.
  • the non-discoloration additive can comprise a blocking agent comprising bovine serum albumin, casein, or combinations thereof.
  • methods of maximizing a level of detection (LOD) in a LAMP analysis can comprise providing a reaction environment and reagents that minimize non-LAMP reaction products.
  • LOD level of detection
  • systems for a chromatic LAMP analysis can comprise a combination of a solid phase reaction medium and LAMP reagents which when stored at a selected temperature (e.g., room temperature at about 25°C) maintain a coloration of the solid phase reaction medium that has a shade that is within 10% of an initial shade of the solid phase medium.
  • a selected temperature e.g., room temperature at about 25°C
  • the combination can maintain the coloration when stored for longer than one or more of: 30 days, 90 days, 365 days, 2 years, or 5 years.
  • the combination can maintain the coloration when stored at a relative humidity between about 40% and 90%.
  • the selected temperature can be any temperature in a range between about - 20 °C and about 37 °C.
  • methods for manufacturing a chromatic LAMP system as recited in the preceding can comprise combining the non-interfering reagent mixture with a substantially non-reactive solid-phase reaction medium such that the noninterfering reagent mixture is held in contact with the substantially non-reactive solid-phase reaction medium.
  • the method can comprise preparing a solution containing the non-interfering reagent mixture, and coating the reagent mixture onto the substantially non- reactive solid-phase reaction medium.
  • the coating can comprise dropping, spraying, dipping, soaking, or misting the solution onto the substantially non-reactive solid phase reaction medium.
  • the non-interfering reagent mixture can be combined with the substantially non-reactive solid-phase reaction medium using a reel-to-reel (R2R) process.
  • a solid phase LAMP reaction medium can comprise a substrate, an adhesive layer disposed on the substrate, a reaction layer disposed on the adhesive layer, or a spreading layer disposed on the reaction layer.
  • the substrate can be an optically transparent material.
  • the adhesive layer can be substantially free of volatile agents.
  • wherein the adhesive layer can be discontinuously disposed on the substrate.
  • the substrate can be an optically clear plastic carrier.
  • the solid phase LAMP reaction medium can further comprise a testing area.
  • the testing area can be defined by at least two segments of discontinuous adhesive layers.
  • the testing area can be defined by at least three segments of discontinuous adhesive layers.
  • the testing area can be defined by at least four segments of discontinuous adhesive layers.
  • the solid phase LAMP reaction medium can further comprise at least one segment that is substantially free of reagents.
  • the reaction layer can comprise reagents including one or more target primers, DNA polymerase, or a resolubilization agent.
  • the reagents can form a composition sufficient to carry out a LAMP reaction.
  • the reaction layer can be discontinuous.
  • the solid phase LAMP reaction medium can further comprise a spreading layer that comprises one or more of glass fiber, nylon, cellulose, polysulfone, poly ethersulfone, cellulose acetate, nitrocellulose, polyester, hydrophilic polytetrafluoroethylene (PTFE), or combinations thereof.
  • the spreading layer can be optically transparent.
  • the solid phase LAMP reaction medium can comprise a spacer material.
  • the spacer material can comprise one or more of glass fiber, nylon, cellulose, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, polystyrene, polyester, hydrophilic polytetrafluoroethylene (PTFE), or combinations thereof.
  • the spacer material can be oriented in the same plane as the reaction layer and oriented between segments of the reaction layer.
  • the reaction layer can have a surface area to thickness ratio from about 30 to about 600.
  • the reaction layer can have a thickness from about 0.05 mm to about 2 mm.
  • the reaction layer can have a width from about 4 mm to about 12 mm and a length from about 4 mm to about 25 mm. In another aspect, a minimum space between segments of the reaction layer can be between about 1.8 mm and about 2.2 mm.
  • methods of testing for a presence of a viral pathogen can comprise providing a saliva sample from a subject, and dispensing the sample into a test environment having a solid phase reaction medium in combination with a LAMP reagent mixture and a pH sensitive dye.
  • the method can comprise minimizing the amount of volatile agents, hygroscopic agents, and non-pH sensitive agents capable of discoloring the solid phase medium.
  • the method can comprise providing an amount of one or more target primers, DNA polymerase, or a re-solubilization agent sufficient to facilitate a LAMP reaction.
  • the method can comprise providing an amount of reverse transcriptase sufficient to facilitate a reverse transcription LAMP (RT-LAMP) reaction.
  • the method can comprise providing an amount of one or more target primers sufficient to detect the viral pathogen.
  • the method can comprise generating a test result in less than one hour after dispensing the sample into the test environment.
  • methods of confirming suitability of a saliva sample for testing with a solid phase LAMP reaction can comprise providing a solid phase reaction medium with at least one test site or test spot and a negative control site.
  • the at least one test site or test spot can include a combination of LAMP reagents and a pH sensitive dye.
  • the negative control site can include a pH sensitive dye and can exclude LAMP reagents.
  • the method can comprise applying the saliva sample to the solid phase reaction medium.
  • the method can comprise confirming activation of the pH sensitive dye on the negative control site.
  • the pH sensitive dye can be at least one of phenol red, phenolphthalein, azolitmin, bromothymol blue, naphtholphthalein, cresol red, or combinations thereof.
  • the LAMP reagents can be substantially free of volatile reagents, pH-affecting reagents, magnesium-containing reagents, or combinations thereof.
  • the LAMP reagents can comprise non-interfering LAMP reagents including DNA polymerase, reverse transcriptase, primers for a target region, or combinations thereof.
  • the method can further comprise providing the test site or test spot defined by at least two segments of discontinuous adhesive layers. In another aspect, the method can comprise providing the test site or spot defined by at least three segments of discontinuous adhesive layers.
  • methods of maximizing accuracy of a positive test result from a solid phase LAMP reaction can comprise providing a solid phase reaction medium with at least three test site or spots, each including a common pH sensitive dye and a combination of LAMP reagents, wherein each site includes a different primer sequence from a target pathogen.
  • the method can comprise initiating a LAMP reaction.
  • the method can comprise confirming a positive test result when at least two of the test site or spots activate the pH sensitive dye and experience a change from a first color to a second color.
  • the method can further comprise providing an amount of reverse transcriptase sufficient to facilitate a reverse transcription LAMP reaction.
  • the pH sensitive dye can be at least one of phenol red, phenolphthalein, azolitmin, bromothymol blue, naphtholphthalein, cresol red, or combinations thereof.
  • the LAMP reagents can be substantially free of volatile reagents, pH-affecting reagents, magnesium-containing reagents, or combinations thereof.
  • the target pathogen can comprise a viral pathogen, a bacterial pathogen, a fungal pathogen, or a protozoa pathogen.
  • the target pathogen can comprise a viral pathogen.
  • the viral pathogen can comprise a dsDNA virus, an ssDNA virus, a dsRNA virus, a positive-strand ssRNA virus, a negative-strand ssRNA virus, an ssRNA-RT virus, or a ds-DNA-RT virus.
  • each primer sequence can match a sequence from a viral target comprising H1N1, H2N2, H3N2, HlNlpdmO9, or SARS-CoV-2.
  • methods of testing for a presence of a target nucleotide sequence can comprise providing a biological sample, dispensing the sample into a test environment having a solid phase reaction medium in combination with a loop-mediated isothermal amplification (LAMP) reagent mixture and a pH sensitive dye.
  • LAMP loop-mediated isothermal amplification
  • the test environment can be substantially free of volatile reagents, pH-affecting reagents, drying agents, or combinations thereof.
  • the method can comprise raising a test environment temperature at a rate of about 0. 1°C per second.
  • the method can comprise providing a heating uniformity in the testing environment that has a variability of less than 1°C.
  • the method can comprise providing a solid phase reaction medium comprising cellulose or glass fiber.
  • the method can comprise providing an amount of reverse transcriptase sufficient to facilitate a reverse transcription LAMP (RT-LAMP) reaction.
  • the biological sample can be at least one of: saliva, mucus, blood, urine, or feces sweat, exhaled breath condensate, or a combination thereof.
  • the method can comprise collecting the biological sample using one or more of a saliva collection device, a nasal swab, a blood collection device, a urine collection device, a sweat collection device, an exhaled breath condensate collection device, or a stool collection device.
  • the target nucleotide sequence can be from at least one of a viral pathogen, a bacterial pathogen, a fungal pathogen, or a protozoan pathogen.
  • the target nucleotide sequence can be from a viral pathogen.
  • the viral pathogen can be selected from the group consisting of: Coronoviridae, Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Adenoviridae, and Parvoviridae.
  • the viral pathogen can be selected from the group consisting of: severe acute respiratory syndrome coronavirus (SARS-CoV-1), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome (MERS), influenza, and H1N1.
  • the target nucleotide sequence can be from a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen.
  • a biological sample testing apparatus can comprise a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye, wherein the apparatus provides a degree of test accuracy of at least about 95% after storage for 6 months when stored at room temperature.
  • LAMP loop-mediated isothermal amplification
  • the apparatus can provide a degree of test accuracy of at least about 95% after storage for 12 months when stored at room temperature.
  • the apparatus can provide a degree of test accuracy of at least about 95% after storage for 2 years when stored at room temperature.
  • a biological sample testing system can comprise a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye, said housing operable to receive a biological sample.
  • the biological sample testing system can comprise a heater configured to isothermally heat the container to an internal temperature sufficient to initiate and sustain a LAMP reaction between the LAMP reagent mixture.
  • the biological sample testing system can comprise a biological sample for a time used to generate a test result via the pH-sensitive dye.
  • the substrate can comprise an optically transparent material.
  • the substrate can engage the solid phase reaction medium via an adhesive.
  • the adhesive can be substantially optically transparent.
  • the substrate can comprise a portion of a housing.
  • the biological sample testing system can comprise an adhesive layer disposed on the substrate, a reaction layer disposed on the adhesive layer, and a spreading layer disposed on the reaction layer.
  • the biological sample testing system can further comprise a spacer layer oriented in the same plane as the reaction layer.
  • the housing can be disposed against the substrate.
  • the housing can be further disposed against the spreading layer.
  • the housing can substantially enclose the substrate, adhesive layer, reaction layer, and spreading layer.
  • FIG. 1 depicts a method of performing a LAMP analysis in accordance with an example embodiment
  • FIG. 2 depicts a method of maximizing accuracy of a chromatic output signal in a solid phase pH-dependent loop-mediated isothermal amplification (LAMP) analysis in accordance with an example embodiment
  • FIG. 3a illustrates a solid phase LAMP reaction medium with three testing sections in accordance with an example embodiment
  • FIG. 3b illustrates a solid phase LAMP reaction medium with two testing sections in accordance with an example embodiment
  • FIG. 3c illustrates a solid phase LAMP reaction medium with four testing sections in accordance with an example embodiment
  • FIG. 3d illustrates a solid phase LAMP reaction medium with three testing sections and without a spreading layer in accordance with an example embodiment
  • FIG. 3e illustrates a solid phase LAMP reaction medium with two testing sections and without a spreading layer in accordance with an example embodiment
  • FIG. 3f illustrates a solid phase LAMP reaction medium with four testing sections and without a spreading layer in accordance with an example embodiment
  • FIG. 4 depicts a method of testing for a presence of a viral pathogen in accordance with an example embodiment
  • FIG. 5 depicts a method of confirming suitability of a saliva sample for testing with a solid phase LAMP reaction in accordance with an example embodiment
  • FIG. 6 depicts a method of maximizing accuracy of a positive test result from a solid phase LAMP reaction in accordance with an example embodiment
  • FIG. 7 depicts a method of testing for a presence of a target nucleotide sequence in accordance with an example embodiment
  • FIG. 8a depicts operations for a biological testing kit in accordance with an example embodiment
  • FIG. 8b illustrates a color chart for a biological testing kit in accordance with an example embodiment
  • FIG. 9 illustrates a paper-based LAMP assembly in accordance with an example embodiment
  • FIG. 10 illustrates material screening of grade 1 and grade 222 chromatography paper in accordance with an example embodiment
  • FIG. 11 shows a reaction in liquid using heat-inactivated SARS-CoV-2 spiked into water in accordance with an example embodiment
  • FIG. 12 illustrates a paper strip format in accordance with an example embodiment
  • FIG. 13 illustrates a solid phase LAMP reaction medium in accordance with an example embodiment
  • FIG. 14 illustrates a solid phase LAMP reaction medium in accordance with an example embodiment
  • FIG. 15A illustrates a comparison between grade 1 chromatography paper and grade 222 chromatography paper in accordance with an example embodiment
  • FIG. 15B illustrates RT-LAMP when incorporating drying at different starting pH of the RT-LAMP reaction mixture
  • FIG. 16 illustrates a test strip format in accordance with an example embodiment
  • FIG. 17 illustrates a test strip assembly process in accordance with an example embodiment
  • FIG. 18A illustrates operations for a biological testing system in accordance with an example embodiment.
  • FIG. 18B illustrates operations for a biological testing system in accordance with an example embodiment
  • FIG. 19A-19F illustrate Schematics and colorimetric characterization of the paperbased device in accordance with an example embodiment
  • FIG. 20A-20C illustrate digital analysis of colorimetric responses on paper in accordance with an example embodiment
  • FIG. 21 A illustrates validation of a device at various concentrations of heat- inactivated SARS-CoV-2 in accordance with an example embodiment
  • FIG. 21B illustrates phenol red color calibration at various pH values in accordance with an example embodiment
  • FIG. 21C illustrates green channel color intensity of RT-LAMP colorimetric response at varying template concentrations in accordance with an example embodiment
  • FIG. 21D illustrates LAMP on chromatography paper using EBT as a colorimetric reporter in accordance with an example embodiment
  • FIG. 21E illustrates the colorimetric response of LAMP on various papers using EBT as an indicator in accordance with an example embodiment
  • FIG. 2 IF illustrates LAMP detection on biodyne A amphoteric paper using EBT as a colorimetric indicator in accordance with an example embodiment
  • FIG. 21 G illustrates the effect of elimination of single reactant on initial color of paper after drying in accordance with an example embodiment
  • FIG. 21H illustrates the effect of Trehalose and Tween 20 on RT-LAMP colorimetric response in accordance with an example embodiment
  • FIG. 211 illustrates the effect of saliva processing on colorimetric response in accordance with an example embodiment
  • FIG. 22A illustrates the effect of plate on RT-LAMP colorimetric response in accordance with an example embodiment
  • FIG. 22B illustrates the effect of caps on RT-LAMP colorimetric response in accordance with an example embodiment
  • FIG. 22C illustrates the effect of the heating method on RT-LAMP colorimetric response in accordance with an example embodiment
  • FIG. 22D illustrates the effect of the ramp rate on RT-LAMP colorimetric response in accordance with an example embodiment
  • FIG. 23A and 23B illustrate colorimetric perception surveys in accordance with an example embodiment.
  • formulation and “composition” are used interchangeably and refer to a mixture of two or more compounds, elements, or molecules. In some aspects, the terms “formulation” and “composition” may be used to refer to a mixture of one or more active agents with a carrier or other excipients.
  • soluble is a measure or characteristic of a substance or agent with regards to its ability to dissolve in a given solvent.
  • the solubility of a substance or agent in a particular component of the composition refers to the amount of the substance or agent dissolved to form a visibly clear solution at a specified temperature such as about 25°C or about 37°C.
  • a “subject” refers to an animal. In one aspect the animal may be a mammal. In another aspect, the mammal may be a human.
  • non-liquid when used to refer to the state of a composition disclosed herein refers to the physical state of the composition as being a semi-solid or solid.
  • solid and “semi-solid” refers to the physical state of a composition that supports its own weight at standard temperature and pressure and has adequate viscosity or structure to not freely flow. Semi-solid materials may conform to the shape of a container under applied pressure.
  • a “solid phase medium” refers to a non-liquid medium.
  • the non-liquid medium can be a material with a porous surface.
  • the non-liquid medium can be a material with a fibrous surface.
  • the non-liquid medium can be paper.
  • a “solid phase medium,” “solid phase base” “solid phase substrate” “solid phase test substrate” “solid phase testing substrate,” “solid phase reaction medium” and the like can be used interchangeably herein and refer to a non-liquid medium, device, system, or environment.
  • the non-liquid medium may be substantially free of liquid or entirely free of liquid.
  • the non-liquid medium can comprise or be a porous material or a material with a porous surface.
  • the non-liquid medium can comprise or be a fibrous material or a material with a fibrous surface.
  • the non-liquid medium can be a paper.
  • non-discoloration additive refers to an additive that minimizes or prevents a color change in the color of the solid phase medium from an original or starting color to a different color for reasons other than nucleotide amplification from a LAMP reaction taking place thereon or therein.
  • a color change can be minimized or reduced as compared to a color change that would take place without the non-discoloration additive present.
  • non-LAMP reaction produced discoloration refers to any discoloration (e.g. change in color from an original color to another color) of the solid phase medium which is not the result of a nucleotide amplification from a LAMP reaction.
  • non-LAMP reaction produced discoloration can refer to discoloration of the solid phase medium resulting from one or more of: a volatile agent, a magnesium-interfering agent, an oxidizing agent, a pH change resulting from causes other than amplification from a LAMP reaction, drying, or combinations thereof.
  • a “volatile agent” refers to an agent that includes a composition that has a high vapor pressure or a low boiling point.
  • ammonium sulfate can be a volatile agent because the ammonium ion can volatilize and leave behind a sulfate.
  • a composition can have a high vapor pressure when the composition is in a gas phase at a temperature of more than about 30 °C.
  • a composition can have a low boiling point when the composition forms is in a gas phase at a temperature of less than about 80 °C
  • a “drying agent” refers to an agent that enhances the drying of the solid-phase medium when compared to the drying of the solid-phase medium without the agent.
  • a “pH-interfering reagent” is a reagent that can affect the pH of a reaction, system, or environment for reasons other than amplification from a LAMP reaction.
  • the ammonium ion can volatilize from ammonium sulfate, and the sulfate ion can react to form sulfuric acid and affect the pH of the reaction in the absence of amplification from the LAMP reaction.
  • a “non-pH sensitive agent” is a reagent that is substantially unaffected by changes in pH.
  • “comprises,” “comprising,” “containing” and “having” and the like can have the meaning ascribed to them in U.S. Patent law and can mean “includes,” “including,” and the like, and are generally interpreted to be open ended terms.
  • the terms “consisting of’ or “consists of’ are closed terms, and include only the components, structures, steps, or the like specifically listed in conjunction with such terms, as well as that which is in accordance with U.S. Patent law.
  • Consisting essentially of’ or “consists essentially of’ have the meaning generally ascribed to them by U.S. Patent law. In particular, such terms are generally closed terms, with the exception of allowing inclusion of additional items, materials, components, steps, or elements, that do not materially affect the basic and novel characteristics or function of the item(s) used in connection therewith. For example, trace elements present in a composition, but not affecting the compositions nature or characteristics would be permissible if present under the “consisting essentially of’ language, even though not expressly recited in a list of items following such terminology.
  • comparative terms such as “increased,” “decreased,” “better,” “worse,” “higher,” “lower,” “enhanced,” “maximized,” “minimized,” and the like refer to a property of a device, component, composition, or activity that is measurably different from other devices, components, compositions or activities that are in a surrounding or adjacent area, that are similarly situated, that are in a single device or composition or in multiple comparable devices or compositions, that are in a group or class, that are in multiple groups or classes, or as compared to the known state of the art.
  • the term “coupled,” as used herein, is defined as directly or indirectly connected in a chemical, mechanical, electrical or nonelectrical manner.
  • Objects described herein as being “adjacent to” each other may be in physical contact with each other, in close proximity to each other, or in the same general region or area as each other, as appropriate for the context in which the phrase is used. “Directly coupled” objects, structures, elements, or features are in contact with one another and may be attached. Further as used in this written description, it is to be understand that when using the term “coupled” support is also afforded for “directly coupled” and vice versa.
  • the term “substantially” refers to the complete or nearly complete extent or degree of an action, characteristic, property, state, structure, item, or result.
  • an object that is “substantially” enclosed would mean that the object is either completely enclosed or nearly completely enclosed.
  • the exact allowable degree of deviation from absolute completeness may in some cases depend on the specific context. However, generally speaking the nearness of completion will be so as to have the same overall result as if absolute and total completion were obtained.
  • the use of “substantially” is equally applicable when used in a negative connotation to refer to the complete or near complete lack of an action, characteristic, property, state, structure, item, or result.
  • compositions that is “substantially free of’ particles would either completely lack particles, or so nearly completely lack particles that the effect would be the same as if it completely lacked particles.
  • a composition that is “substantially free of’ an ingredient or element may still actually contain such item as long as there is no measurable effect thereof.
  • the term “about” is used to provide flexibility to a numerical range endpoint by providing that a given value may be “a little above” or “a little below” the endpoint. Unless otherwise stated, use of the term “about” in accordance with a specific number or numerical range should also be understood to provide support for such numerical terms or range without the term “about”. For example, for the sake of convenience and brevity, a numerical range of “about 50 angstroms to about 80 angstroms” should also be understood to provide support for the range of “50 angstroms to 80 angstroms.” Furthermore, it is to be understood that in this specification support for actual numerical values is provided even when the term “about” is used therewith.
  • RT- LAMP reverse-transcription loop-mediated isothermal amplification
  • a pathogen e.g., SARS-CoV-2
  • diluted saliva e.g., 5 % v/v in water
  • RT-LAMP is a nucleic acid amplification technique conducted at a constant temperature with adequate diagnostic performance especially during the acute phase of infection. Since RT-LAMP can be conducted at a constant temperature, expensive thermal cycling equipment is not used. Additionally, existing colorimetric reporters for LAMP products do not use fluorescence readers. Consequently, this test is suitable for use in point-of-care settings and is amenable to rapid development and scale-up, making it appropriate for use in public health emergencies.
  • RT-LAMP can be implemented on microfluidic paper-based analytical devices (pPADs) to detect various pathogens (e.g., SARS-CoV-2) where image analysis can be performed using a portable electronic device to distinguish between positive and negative responses.
  • pathogens e.g., SARS-CoV-2
  • a high-contrast RT-LAMP reaction on paper can provide a color change that can be visible to the naked eye.
  • polystyrene spacers can be used for preventing crosstalk between samples. The polystyrene spacers can be amenable to roll-to-roll fabrication for scale up of production.
  • Nucleic-acid-based COVID-19 diagnosis methods use pre-processing to provide results.
  • on-paper colorimetric detection of SARS-CoV-2 can be performed with minimal pre-processing.
  • the device can have a sensitivity and specificity that can detect SARS-CoV-2 on paper without pre-amplification.
  • Other assays conducted in solution may not be as scalable during manufacturing as paper-based assays.
  • the assay disclosed herein uses a dilution operation that can be completed in seconds, whereas other assays use various operations such as treatment with protease, heatinactivation, and/or RNA extraction to detect SARS-CoV-2 (operations completed in at least 10 minutes and using additional equipment).
  • the solidphase medium should support the LAMP reaction without interference with it or the LAMP reaction indicator.
  • the solid-phase medium is hydrated with a biological sample to allow the LAMP reaction to proceed and thereafter the results are read.
  • various reagents can interfere with the LAMP reaction or the subsequent reading of the results.
  • care can be taken to minimize or avoid possible challenges that may arise with respect to providing a biological sample, hydrating solid phase medium with a sample, integrating LAMP reagents into the solid phase medium, carrying out the LAMP analysis, and obtaining a clear test output signal that can be interpreted without difficulty.
  • a loop- mediated isothermal amplification (LAMP) reaction assembly can comprise a substantially hygroscopic agent free LAMP reagent mixture in combination with a solid-phase reaction medium.
  • the LAMP reagent mixture when substantially free of hygroscopic agents, can minimize or avoid difficulties occurring during drying of the solid-phase reaction medium.
  • hygroscopic agents when used, they or the solid-phase reaction medium may not dry entirely, or may rehydrate to a degree upon storage and may interfere with the original color of the solid-phase reaction medium which can skew the test results from the LAMP process.
  • a hygroscopic agent can be an agent that absorbs more than about 10 wt % when between about 40% and about 90% relative humidity (RH) at 25° C.
  • a hygroscopic agent can comprise but is not limited to, one or more of glycerol, ethanol, methanol, calcium chloride, potassium chloride, calcium sulfate, the like, or combinations thereof.
  • a LAMP reaction that contains a hygroscopic agent, such as glycerol can contribute to the instability of reagents in the solid-phase medium because the hygroscopic agent can attract water. Therefore, an excessive amount of hygroscopic agents in the solid-phase reaction medium should be avoided.
  • the substantially hygroscopic agent free LAMP reagent mixture can comprise one or more of DNA polymerase, reverse transcriptase, target primers, or combinations thereof.
  • DNA polymerase can be included when the LAMP reaction is either a LAMP reaction or a reverse transcription LAMP (RT-LAMP) reaction.
  • RT-LAMP reverse transcription LAMP
  • the substantially hygroscopic agent free LAMP reagent can further include reverse transcriptase used to reverse transcribe RNA to cDNA.
  • the solid-phase reaction medium can be substantially free of magnesium-interfering agents.
  • Magnesium can interfere with the LAMP reaction in a few ways. First, magnesium can be a cofactor for DNA polymerase and should be tightly monitored within a target concentration range to allow the DNA polymerase to facilitate the LAMP reaction. Second, when a magnesium-sensitive indicator is used for the LAMP reaction, then magnesium interfering agents can invalidate the results of the LAMP reaction or complicate the analysis of the results.
  • the magnesium-interfering agents can include magnesium- containing compounds and chelating agents that interfere with magnesium.
  • the magnesium-interfering agents can be substantially free of magnesium including, but not limited to: Mg 2+ , Mg 1+ , magnesium carbonate, magnesium chloride, magnesium citrate, magnesium hydroxide, magnesium oxide, magnesium sulfate, magnesium sulfate heptahydrate, the like, or combinations thereof. Because some solid-phase reaction medium might have some buffer capacity, residual ions, or chelating agents that can interfere with magnesium, the concentration of magnesium - a cofactor for BST enzymes (e.g., DNA polymerase) - can be affected and interfere with the LAMP reaction.
  • BST enzymes e.g., DNA polymerase
  • the concentration of magnesium should be controlled within a target magnesium range to facilitate the LAMP reaction.
  • the composition can contain less than one or more of: 1.0 wt%, 0.5 wt%, 0.1 wt%, or 0.01 wt% of magnesium.
  • the solid-phase reaction medium can have several characteristics to facilitate the LAMP reaction.
  • the solid-phase reaction medium can be hydrophilic, absorbent, porous, and inert.
  • the solid-phase reaction medium can be hydrophilic when the contact angle between the surface and edge of a droplet is less than about 90 degrees.
  • the solid-phase reaction medium can be absorbent as measured by the degree to which paper can take up an amount of liquid.
  • the solid-phase reaction medium can be porous when the solidphase reaction medium has a pore size of greater then at least 1 micron and less than or equal to one or more of about 100 microns, about 75 microns, about 50 microns, about 25 microns, about 10 microns, about 5 microns, or about 1 micron.
  • the solid-phase reaction medium can be inert when the medium does not interfere with the LAMP reaction.
  • the solid-phase reaction medium can also be inert when the medium does not interfere with the indication resulting from the LAMP reaction.
  • the solid-phase reaction medium can comprise or include.
  • the solid-phase reaction medium can comprise one or more of nylon, polysulfone, poly ethersulfone, cellulose acetate, nitrocellulose, hydrophilic polytetrafluoroethylene (PTFE), the like, or combinations thereof.
  • the solid-phase reaction medium can be a cellulose-based medium, such as Grade 1 chromatography paper, Grade 222 chromatography paper, the like, or combinations thereof.
  • the solidphase reaction medium can have several physical properties that can accommodate or enhance the LAMP reaction and avoid interference with the indication or signal output resulting from the LAMP reaction.
  • the solid-phase reaction medium can have a surface area to thickness ratio between about 30 and about 600.
  • the solid-phase reaction medium can have a surface area to thickness ratio between about 60 and about 400.
  • the solid-phase reaction medium can have a surface area to thickness ratio between about 100 and about 200.
  • the solid-phase reaction medium can be a cellulose-based medium that can have a surface area to thickness ratio between about 30 and about 600.
  • the cellulose-based medium can have a pore size of greater than at least 1 micron and less than or equal to one or more of about 100 microns, about 75 microns, about 50 microns, about 25 microns, about 10 microns, about 5 microns, or about 1 micron.
  • the thickness of the solid-phase reaction medium can contribute to the total reaction time for the LAMP reaction, the flow rate through the solid-phase reaction medium, the color contrast when a colorimetric indicator is used, the uniformity of the colorimetric results, the concentration of the reagents in the solid-phase reaction medium, and the like.
  • the solid-phase reaction medium can comprise grade 222 chromatography paper, which provides increased uniformity relative to the uniformity of grade 1 chromatography paper because grade 222 chromatography paper is thicker than Grade 1 chromatography paper. Consequently, grade 222 chromatography paper can concentrate reagents in a smaller surface area compared to grade 1 chromatography paper.
  • the chromatography paper can be grade 222 having a surface area of about 5 mm by about 5 mm to provide desired surface area to thickness ratio.
  • the grade 1 chromatography paper can have cross sectional dimensions of 20 mm in length and 5 mm in width with a 0. 18 mm thickness to provide a surface area to thickness ratio of about 555.
  • grade 222 chromatography paper can have cross sectional dimensions of 5 mm in length and 5 mm in width with a 0.83 mm thickness to provide a surface area to thickness ratio of about 30.
  • this example illustrates that a surface area to thickness ratio of about 30 (e.g., for the grade 222 chromatography paper) can provide increased uniformity compared to a surface area to thickness ratio of about 555 (e.g., for grade 1 chromatography paper).
  • the solid-phase reaction medium can comprise one or more of paper or glass-fiber.
  • the paper can comprise one or more of alpha cellulose, beta cellulose, gamma cellulose, the like, or combinations thereof.
  • the glass-fiber can comprise one or more of A-glass, E-glass, S-glass, R-glass, C- glass, T-glass, D-glass, M-glass, ECR glass, the like, or combinations thereof.
  • the reaction assembly can include an adhesive.
  • the adhesive can be used to adhere various segments of the solid-phase reaction medium to each other.
  • the reaction assembly can further comprise an adhesive substantially free of magnesium-interfering agents, hygroscopic agents, or combinations thereof.
  • the adhesive can be substantially free of magnesium-interfering agents to avoid interference between magnesium and DNA polymerase and to avoid complications in reading the LAMP results when using magnesium-based indicators.
  • the reaction assembly can also include a spreading layer.
  • the spreading layer can facilitate a uniform spreading of a biological sample throughout the different sections of the solid-phase reaction medium.
  • the spreading layer can be less hydrophilic than the solid-phase reaction medium. Having a spreading layer that is less hydrophilic than the solid-phase reaction medium can facilitate the uniform spreading of the biological sample because the biological sample will diffuse away from the less hydrophilic spreading layer towards the more hydrophilic solid-phase reaction medium.
  • a method of manufacturing a LAMP reaction assembly as recited herein can comprise combining the substantially hygroscopic agent free LAMP reagent mixture with the solid-phase reaction medium such that the reagent mixture is held in contact with the solid-phase reaction medium.
  • the reagent mixture can be held in direct contact with the solid-phase reaction medium.
  • the reagent mixture can be held in indirect contact with the solid-phase reaction medium.
  • an intervening material e.g., an antioxidant
  • the color of the solid-phase reaction medium can be affected by agents that do not result from the LAMP reaction.
  • volatile agents such as ammonium sulfate
  • a pH-based indicator can be used to read the results of the LAMP reaction, then these non-LAMP reactions can prevent a correct reading of the results or can further complicate interpretation of the results.
  • the method can comprise controlling discoloration using a nondiscoloration additive.
  • the non-discoloration additive can comprise a sugar, a buffer, a blocking agent, the like, or combinations thereof.
  • the sugar can comprise one or more of trehalose, glucose, sucrose, dextran, the like, or combinations thereof.
  • the blocking agent can comprise bovine serum albumin, casein, the like, or combinations thereof.
  • the sugar can prevent the impact of the non-LAMP reagent pH changes.
  • the buffer can prevent interference with the LAMP reaction or the results of the LAMP reaction by preventing the impact of pH changes that arise from factors other than the LAMP reaction.
  • the blocking agent can prevent the impact from factors other than the LAMP reaction by blocking the actions of various enzymes, such as RNase or DNase, on the nucleic acids to be analyzed (e.g., RNA from a virus or DNA from a pathogen).
  • a method 100 of performing a LAMP analysis can comprise providing a LAMP reaction assembly as recited in this disclosure, as shown in block 110.
  • the method can further comprise applying a biological sample to the reaction assembly, as shown in block 120.
  • the method can further comprise heating the assembly to a temperature sufficient to initiate LAMP reaction, as shown in block 130.
  • the method can further comprise maintaining the temperature for a time sufficient to complete the LAMP reaction, as shown in block 140.
  • the biological sample can be one or more of saliva, mucus, blood, urine, feces, sweat, exhaled breath condensate, or combinations thereof.
  • the biological sample can be saliva.
  • the method can further comprise detecting a viral pathogen.
  • the LAMP analysis can be reverse transcription LAMP (RT-LAMP).
  • the temperature sufficient to initiate a LAMP reaction can be in a temperature range of from about 50 °C to about 60 °C. In another aspect, the temperature sufficient to initiate a LAMP reaction can be in a temperature range of from about 60 °C to about 70 °C. In another example, the isothermal temperature can be a temperature within a range that differs by less than 5 °C. In another aspect, the temperature can be maintained the temperature sufficient to complete the LAMP reaction for more than one or more of: 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, or 120 minutes. In another aspect, the temperature can be maintained the temperature sufficient to complete the LAMP reaction for less than one or more of: 15 minutes, 30 minutes, 45 minutes, 60 minutes, 75 minutes, 90 minutes, 105 minutes, or 120 minutes.
  • the LAMP reaction assembly can be manufactured to enhance its uniformity, its shelf-life or storage life, and its test validity.
  • the LAMP reaction assembly can be manufactured using one or more of: slitting (splitting rolls into thinner rolls), singulation (individual pieces cut by guillotine, rotary die, or laser), reagent coating (reagents dipped, sprayed or dispensed and dried), card lamination (plastic backing added to reels), the like, or combinations thereof.
  • the LAMP reaction assembly can be manufactured using one or more of: splitting rolls into thinner rolls; individual pieces cut by guillotine or rotary die; reagent coating using reagent dipping, card lamination using plastic backing added to reels, the like, or combinations thereof.
  • the reagent mixture should be substantially free of interfering reagents.
  • the interfering reagents can include oxidizing agents and pH interfering agents.
  • a system for a chromatic loop-mediated isothermal amplification (LAMP) analysis can comprise a substantially non-reactive solid phase reaction medium, and a non-interfering reagent mixture.
  • the substantially non-reactive solid phase reaction medium can be substantially free of oxidizing agents and pH-interfering agents.
  • the non-interfering reagent mixture can comprise one or more target primers, DNA polymerase, a re-solubilization agent, or combinations thereof.
  • an oxidizing agent can include, but is not limited to, one or more of: O2, O3, H2O2, F2, Ch, halogens, HNOs, nitrates, H2SO4, H2S2O8, H2SO5, hypochlorite, chlorite, chlorate, perchlorate, chromium compounds, permanganate, sodium perborate, nitrous oxide, NO2, N2O4, KNOs, NaBiCh, cerium compounds, lead dioxide, the like, or combinations thereof.
  • the non-reactive solid phase reaction medium can include one or more of: oxygen absorbers, desiccants, the like, or combinations thereof to prevent oxidation of the non-reactive solid phase reaction medium.
  • the cellulose can be pretreated by heat cycling the cellulose to saturate the oxidation sites.
  • an antioxidant can be added to prevent oxidation.
  • a dye indicator e.g., phenol red
  • the substantially non-reactive solid phase reaction medium can contain less than one or more of: 1.0 wt%, 0.5 wt%, 0.1 wt%, or 0.01 wt% of the oxidizing agents.
  • pH-interfering agents can prevent a proper interpretation of the results of the LAMP reaction or further complicate the signal output of the LAMP reaction.
  • a pH-interfering agent can include, but is not limited to, one or more of: volatile reagents, pH-affecting reagents, magnesium-containing reagents, or combinations thereof.
  • pH-affecting reagents When pH-affecting reagents are included, the resulting change in pH can complicate the analysis of the pH-based results from the LAMP reaction. In some cases, the inclusion of the pH-affecting reagents can be compensated for, and the analysis can be adjusted to allow adequate test interpretation. However, in other cases, the pH-affecting reagents can introduce unclarity into the interpretation of the pH-based results.
  • the substantially non-reactive solid phase reaction medium can be substantially free of pH-affecting reagents.
  • the pH-affecting reagents can include acids, bases, or combinations thereof that can interfere with a pH-sensitive signal.
  • the substantially non-reactive solid phase reaction medium can contain less than one or more of: 1.0 wt%, 0.5 wt%, 0.1 wt%, or 0.01 wt% of the pH-affecting reagents.
  • the volatile component can volatize and leave behind a component that can interfere with the pH-sensitive output signal or leave behind a component that can further react to interfere with the pH-sensitive output signal.
  • ammonium carbonate can form an ammonium ion that volatizes and a carbonate ion that reacts to form carbonic acid.
  • the carbonic acid can interfere with the pH-sensitive output signal by lowering the pH in the absence of a positive result (e.g., presence of a target pathogen and LAMP-induced amplification) from the LAMP reaction.
  • the non-reactive solid phase medium can be substantially free of volatile agents as defined herein.
  • the substantially non-reactive solid phase reaction medium can be substantially free of magnesium reagents as otherwise disclosed herein.
  • the substantially non-reactive solid phase medium can be comprised of various materials.
  • the substantially non-reactive solid phase reaction medium can comprise glass fiber, nylon, cellulose, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, hydrophilic PTFE, the like, or combinations thereof.
  • the substantially non-reactive solid phase reaction medium can be hydrophilic, absorbent, inert, and porous as disclosed herein.
  • the buffering capacity of the non-reactive solid phase medium can affect the LAMP reaction.
  • a strong buffer can prevent the changes in pH that are to be detected from the LAMP reaction.
  • a weak buffer can lead to large swings in pH even in the absence of LAMP-induced amplification.
  • the substantially non-reactive solid phase reaction medium can have a buffering capacity from about 0.01 mM to about 5 mM.
  • a heat inactivated virus can be spiked into bio-banked saliva at a limit-of- detection on the order of about 500 copies per 25 pl of sample volume.
  • the buffering capacity and pH of bio-banked saliva can differ from freshly collected saliva. Therefore, the limit of detection (LOD) of freshly collected saliva can be adjusted based on the buffering capacity differences and pH differences between bio-banked saliva and freshly collected saliva.
  • the pH-sensitive output signal from the non-reactive solid-phase reaction medium can be interpreted by a technician without specialized instrumentation.
  • a colorimetric reader can provide an additional level of precision and accuracy.
  • the substantially non-reactive solid phase reaction medium can have a maximum absorbance wavelength (Xmax) within a testing range when combined with a pH sensitive dye.
  • Xmax can be within a testing range of about 443 nm to about 570 nm. Therefore, when the pH-sensitive dye is phenol red and the maximum absorbance wavelength is within a testing range, a technician can use a colorimetric reader to detect a positive or negative result.
  • the system can further comprise components in addition to the non- reactive solid-phase reaction medium.
  • the system can further comprise an adhesive, a spreading layer, a spacer, a plastic carrier, or combinations thereof.
  • each of the adhesive, spreading layer, spacer, and plastic carrier can be substantially free of oxidizing agents and pH-interfering agents as disclosed herein.
  • a method 200 of maximizing accuracy of a chromatic output signal in a solid phase pH-dependent loop-mediated isothermal amplification (LAMP) analysis can comprise: providing a solid phase reaction medium that minimizes non-LAMP reaction produced discoloration, as shown in block 210, and performing the LAMP analysis on the solid phase reaction medium, as shown in block 220.
  • LAMP pH-dependent loop-mediated isothermal amplification
  • the method can further comprise controlling non-LAMP produced discoloration from non-LAMP reaction produced protons. In another aspect, the method can further comprise controlling non-LAMP reaction produced discoloration using a nondiscoloration additive.
  • Anon-discoloration additive can prevent undesirable changes in the colorimetric response due to non-LAMP amplification.
  • the non-discoloration additive can comprise a sugar, a buffer, a blocking agent, the like, or combinations thereof.
  • the sugar can comprise one or more of trehalose, glucose, sucrose, dextran, the like, or combinations thereof.
  • the concentration of the sugar can be from about 0.01 mM to about 1 M when used on the solid-phase medium. In another example, the concentration of the sugar can be from about 10 mM to about 500 mM when used on the solid-phase medium . In yet another example, the concentration of the sugar can be from about 200 mM to about 400 mM when used on the solid-phase medium .
  • a buffer can include one or more of phosphate-buffered saline (PBS), Dulbecco’s PBS, Alsever’s solution, Tris-buffered saline (TBS), water, HEPES, BICINE, balanced salt solutions (BSS), such as Hank’s BSS, Earle’s BSS, Grey’s BSS, Puck’s BSS, Simm’s BSS, Tyrode’s BSS, BSS Plus, Ringer’s lactate solution, normal saline (i.e. 0.9% saline), !4 normal saline, the like, or combinations thereof.
  • PBS phosphate-buffered saline
  • Dulbecco’s PBS Dulbecco’s PBS
  • Alsever Tris-buffered saline
  • TBS Tris-buffered saline
  • HEPES HEPES
  • BICINE balanced salt solutions
  • BSS balanced salt solutions
  • the concentration of the buffer can be from about 10 pM to about 20 mM when used on the solidphase medium. In another example, the concentration of the buffer can be from about 100 pM to about 10 mM when used on the solid-phase medium . In yet another example, the concentration of the buffer can be from about 100 pM to about 500 pM when used on the solid-phase medium.
  • a blocking agent can include one or more of bovine serum albumin, casein, or combinations thereof.
  • the concentration of the blocking agent can be from about 0.01 wt% to about 5 wt% when used on the solid-phase medium.
  • the concentration of the blocking agent can be from about 0.01 wt% to about 1 wt% when used on the solid-phase medium.
  • the concentration of the blocking agent can be from about 0.02 wt% to about 0.06 wt% when used on the solid-phase medium.
  • a method of maximizing a level of detection (LOD) in a loop- mediated isothermal amplification (LAMP) analysis can comprise providing a reaction environment and reagents that minimize non-LAMP reaction products.
  • the reaction environment can be substantially free of one or more of oxidizing agents, pH- interfering agents, hygroscopic reagents, magnesium-interfering reagents, the like, or combinations thereof.
  • a system for a chromatic loop-mediated isothermal amplification (LAMP) analysis can comprise a combination of a solid phase reaction medium and LAMP reagents which when stored at 25°C can maintain a coloration of the solid phase reaction medium that is within 10% of an initial shade of the solid phase medium.
  • the combination of the solid phase medium and the LAMP reagents can maintain the coloration when stored for longer than one or more of: 30 days, 90 days, 365 days, 2 years, 3 years, or 5 years.
  • the combination of the solid phase medium and the LAMP reagents can maintain the coloration when stored at a relative humidity between about 40% and 90%.
  • a method for manufacturing a chromatic LAMP system can comprise combining the non-interfering reagent mixture with a substantially non-reactive solid-phase reaction medium such that the non-interfering reagent mixture is held in contact with the substantially non-reactive solid-phase reaction medium.
  • the non-interfering reagent mixture can be held in direct contact with the solid-phase reaction medium.
  • the non-interfering reagent mixture can be held in indirect contact with the solid-phase reaction medium.
  • an intervening material e.g., an antioxidant
  • an intervening material can enhance the LAMP reaction.
  • the method can include: preparing a solution containing the noninterfering reagent mixture, and coating the reagent mixture onto the substantially non- reactive solid-phase reaction medium.
  • the coating can comprise dropping, spraying, dipping, soaking, or misting the solution onto the substantially non-reactive solid phase reaction medium.
  • the manufacturing process can affect the shelf-life stability or uniformity of the system for the LAMP analysis.
  • the non-interfering reagent mixture can be combined with the substantially non-reactive solid-phase reaction medium using a reel-to-reel (R2R) process.
  • the process can be multiplexed by including multiple controls on the same solid-phase medium.
  • the test validity can be verified using a positive control.
  • the LAMP reaction can test a saliva sample for a saliva DNA or RNA biomarker to verify that the LAMP reaction is functioning as expected.
  • the test validity can be verified using a negative control.
  • the LAMP reaction can test a saliva sample that does not include the pathogen.
  • a second way of multiplexing LAMP can be by including primers that target multiple, different pathogens on the same solid-phase medium.
  • the test validity can be verified by testing for a viral pathogen and a bacterial pathogen on the same solid-phase medium to further characterize the biological sample.
  • a third way of multiplexing LAMP can be by testing for the same pathogen using different target primers.
  • a first section of the solid-phase medium can test using a primer set for a first protein of a viral pathogen
  • a second section of the solid-phase medium can test using a second primer set for a second protein of the viral pathogen
  • a third section of the solid phase medium can test using a third primer set for a third protein of the viral pathogen.
  • Each of the primers can be targeted to distinct regions of the genome of the viral pathogen to eliminate false negatives and false positives.
  • a solid phase reaction medium 300a for conducting a LAMP analysis can comprise a substrate 302, an adhesive layer 304 disposed on the substrate 302, a reaction layer 306 including test spots or reaction locations or segments 305a, 305b, 305c and spacers 307a, 307b, 307c disposed on the adhesive layer 304, and a spreading layer 308 disposed on the reaction layer 306.
  • the test spots 305a, 305b, and 305c can include or otherwise hold reagents including one or more target primers, DNA polymerase, a re-solubilization agent, etc.
  • the reagents can form a composition sufficient to carry out a LAMP reaction.
  • test spot 305a can be a positive control (e.g., test for a known saliva DNA or RNA biomarker)
  • test spot 305b can be negative control (e.g., test for a colorimetric result without including all of the reagents used for the LAMP reaction)
  • test spot or reaction segment 305c can test for the target pathogen.
  • test spot 305a can test for influenza
  • test spot 305b can test for a bacterial infection
  • test spot 305c can test for a fungal infection.
  • the dimensions of the reaction locations or segments 305a-305c can impact the multiplexing potential.
  • the reaction segments 305a-305c can have a thickness from about 0.05 mm to about 2 mm.
  • the reaction segments 305a-305c can have a width from about 4 mm to about 12 mm and a length from about 4 mm to about 25 mm.
  • the reaction locations 305a-305c can be spatially discontinuous.
  • the reaction segments 305a-305c can have a surface area to thickness ratio from about 30 to about 600.
  • the solid-phase reaction medium 300a can be configured to receive a biological fluid that can flow transversely across the spreading layer 308 and that can migrate vertically down into the test spots 305a-305c of the reaction layer 306.
  • the test spots 305a- 305c can contain all the components used for a RT-LAMP or LAMP reaction to occur.
  • the test spots 305a-305c can contain a re-solubilization agent (e.g., a surfactant), enzymes (e.g., DNA polymerase, reverse transcriptase, DNase inhibitors, or RNase inhibitors), stabilizers (e.g., blocking agents such as BSA or casein), a colorimetric indicator (e.g., a magnesium colorimetric indicator, a pH colorimetric indicator, or a DNA intercalating colorimetric indicator), and a buffer (e.g., 20mM Tris).
  • a re-solubilization agent e.g., a surfactant
  • enzymes e.g., DNA polymerase, reverse transcriptase, DNase inhibitors, or RNase inhibitors
  • stabilizers e.g., blocking agents such as BSA or casein
  • a colorimetric indicator e.g., a magnesium colorimetric indicator, a pH colorimetric indicator, or a DNA intercalating colorimetric indicator
  • the solid-phase reaction medium 300a can be configured to receive an agent that can speed up the reaction, increase sensitivity, or a combination thereof.
  • BSA can speed up the reaction and increase sensitivity.
  • the inclusion of BSA can also introduce pH variations that can interfere with the readability of the results. Therefore, in some examples, the stabilizer can be casein, polysorbate 20, the like, or a combination thereof.
  • the reaction segments or spots (e.g. test spots) 305a-305c can comprise any suitable material disclosed herein.
  • the reaction segments 305a-305c can comprise one or more of glass fiber, nylon, cellulose, poly sulfone, polyethersulfone, cellulose acetate, nitrocellulose, hydrophilic PTFE, the like, or combinations thereof.
  • the pore size of the reaction segments or spots 305a-305c can be from about 1 to about 100 microns.
  • the reaction segments or spots 305a-305c can be optically clean and smooth in appearance.
  • the reaction segments 305a-305c can provide a uniform end-color in a read zone for accurate and precise signal output or detection.
  • a biological sample can slowly migrate vertically downward into the reaction segments 305a- 305c.
  • the end-color intensity of the reaction segments 305a-305c can be measured by a user with optical observation and comparison to a color chart or scale or with a handheld LED meter as percent reflectance units and converted to copies of RNA or DNA per reaction using a curve set calibrated against a laboratory reference instrument, or as an optical image obtaining RGB values or pixel count which can be calibrated against a laboratory reference instrument.
  • the concentration of RNA or DNA can be determined by the end-color intensity at a selected time or by kinetic rate determination.
  • the solid phase LAMP reaction medium 300a can further comprise reaction segments 305a-c.
  • at least one section can be substantially free of reagents (e.g., 305a can be substantially free of reagents).
  • the reaction segments 305a-c can be defined by at least three sections of discontinuous adhesive layers 304. The three reaction segments 305a, 305b, and 305c can include designations for testing of the same pathogen, one pathogen with multiple controls, or multiple different pathogens with or without specific positive or negative controls.
  • reaction segments 305a-c can be designated and configured for testing in nearly any array so as to provide any desired parameters or protocols that yield a specific test for a specific outcome with a high degree of accuracy confidence.
  • reaction layer 306 can be configured with test spots 305a-c in a variety of numbers and location arrangements. For example, 2, 3, 4, 5, 6, 7, 8, 9, 10, or any other reasonable number of test spots may be included in reaction layer.
  • test spots or reaction segments can be arranged linearly, side-by-side, or in nearly any other desired spatial arrangement within reaction layer 306.
  • a solid phase LAMP reaction medium 300b can include the reaction segment 305a and 305b coupled between adhesive layer 304 and spreading or distribution layer 308.
  • at least one reaction segment e.g., 305a or 305b
  • at least one of the reaction segments e.g., 305a or 305b
  • can be configured to test for a target pathogen e.g. will contain or otherwise support the reagents for a selected LAMP reaction).
  • a solid phase LAMP reaction medium 300c can comprise a reaction layer 306 with reaction segments or spots 305a, 305b, 305c, 305d coupled between adhesive layer 304 and spreading layer 308.
  • Each reaction segment can be separated by a spacer (e.g., 307a, 307b, 307c, 307d, 307e) from an adjacent reaction segment or spot.
  • a solid phase LAMP reaction medium 300d can comprise a substrate 302, an adhesive 304, a reaction layer 306 with reaction segments or spots 305a, 305b, and 305c without including a spreading layer.
  • the sample can be deposited on each section of the reaction layer 305a, 305b, 305c separately, or simultaneously. Additionally, in this embodiment, no spacers are present between the adjacent reaction segments. However, in some embodiments, spacers can be included without the spreading layer 308 present.
  • a solid phase LAMP reaction medium 300e can comprise a substrate 302, an adhesive 304, and a reaction layer 306 having reaction segments or test spots 305a and 305b without including a spreading layer or any spacers. Again, spacers may still be included in another embodiment without also including the spreader layer 308.
  • the sample can be deposited on each section of the reaction layer 305a and 305b separately and/or collectively.
  • a solid phase reaction medium 300f that can be used for a LAMP analysis, can comprise a substrate 302, an adhesive 304, a reaction layer 306 having reaction segments 305a, 305b, 305c, and 305d without including a spreading layer and without having any spacers.
  • spacers could be included between the adjacent reaction segments if desired, yet without including a spreading layer.
  • the sample can be deposited on each section of the reaction layer 305a, 305b, 305c, 305d separately and/or collectively.
  • a spreading layer 308 can be present with test spots or reaction segments coupled between the spreading layer and an adhesive 304, but without including any spacers.
  • the components of the solid phase reaction medium can be selected to accommodate the needs of the test in order to provide the most accurate outcome or in order to accommodate any manufacturing needs or reap certain other benefits.
  • the substrate 302 can be an optically transparent material. In another aspect, the substrate 302 can be an optically clear plastic carrier. In another aspect, the adhesive layer 304 can be substantially free of volatile agents. In another aspect, the adhesive layer 304 can be substantially free of agents that can interfere with a LAMP reaction. In another aspect, the adhesive layer 304 can be either continuously or discontinuously disposed on the substrate.
  • the adhesive layer can comprise various materials.
  • the reaction layer 306 can comprise one or more of glass fiber, nylon, cellulose, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, hydrophilic PTFE, the like, or combinations thereof.
  • an adhesive layer 304 can comprise an inert adhesive that does not affect the color change of the reaction segments or test spots in the reaction layer.
  • the reaction layer 306 can be substantially free of chelating agents, magnesium, excess buffering capacity, pH-affecting reagents, or combinations thereof.
  • the amount of adhesive can be minimized to prevent interference between the adhesive layer 304 and the reaction segments 305a-c.
  • the spreading layer can be configured to enhance the distribution and uniformity of the biological sample over the reaction segments 305a-305c.
  • the spreading layer 308 can distribute or meter the saliva sample across the surface of the reaction layer 306.
  • the spreading layer 308 can provide a uniform or substantially uniform concentration of saliva sample between the interface of the spreading layer 308 and the reaction layer 306.
  • the spreading layer 308 can be one or more of a mesh material, an isotropic porous material having the same porosity throughout, or an anisotropic layer having a gradient in porosity, the like, or combinations thereof.
  • an anisotropic layer can have pore sizes in the range of about 1 to about 100 microns.
  • the spreading layer 308 can be hydrophilic to a degree sufficient to absorb and spread the sample. In another aspect, spreading layer 308 can be less hydrophilic than the reaction layer 306 underneath to allow the sample to be drawn out of the spreading layer 308 and into the reaction layer 306.
  • Precise permeability of the spreading layer 308 can be used for uniformly distributing the biological sample across the surface of the reaction layer 305a-c equally and evenly when a homogeneous biological sample is provided.
  • the surface of the spreading layer 308 can be in direct contact with the reaction layer 305a-c for uniform vertical transfer of the biological sample through a lateral migration of the biological sample.
  • the spreading layer 308 can comprise one or more of glass fiber, nylon, cellulose, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, polyester, hydrophilic polytetrafluoroethylene (PTFE), the like, or combinations thereof.
  • the spreading layer 308 can be optically transparent.
  • the material can be chemically treated to enhance the distribution of the biological sample across multiple reaction segments 305a-305c.
  • Adequate spacing between reaction segments or test spots 305a-305c can minimize or eliminate the probability of cross-contamination between each reaction segment.
  • reaction segment 305a may contaminate an adjoining segment such as 305b when the spacing between the two sections allows reagents from 305a to flow into 305b.
  • the solid phase LAMP reaction medium 300a can further comprise spacers 307a, 307b, 307c, and 307d that can enforce a minimum space between reaction segments 305a-c that is from about 1.0 mm mm to about 3.0 mm (e.g., 2.5 mm).
  • spacers 307a-307d can have a height that is greater than or equal to the reaction segments or test spots 305a-305d to create a physical barrier therebetween (e.g., when sample is separately administered to each test spot).
  • the spacer height can be determined as a measure of the distance between the substrate 302 and a top surface of the spacer(s).
  • the reaction segment height can be determined as a measure of the distance between the substrate 302 and a top surface of the reaction segment.
  • the spacers can have a height that is from 0 to 50% greater than a height of the reaction segments.
  • spacers 307a-307d can have a height that is less than or equal to the reaction segments or test spots 305a-305d to create a physical barrier therebetween (e.g., when sample is separately administered to each test spot).
  • the reaction segment height can be determined as a measure of the distance between the substrate 302 and a top surface of the reaction segment.
  • the spacers can have a height that is from 0 to 50% less than a height of the reaction segments.
  • the spacers 307a-d can include, but are not limited to, one or more of polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, polystyrene, polyester, hydrophilic polytetrafluoroethylene (PTFE), the like, or combinations thereof.
  • the spacers 307a-d can include, but are not limited to, glass fiber, nylon, cellulose, the like, or combinations thereof.
  • the spacers 307a-d can comprise a hydrophobic material (e.g., polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, polystyrene, polyester, hydrophilic polytetrafluoroethylene (PTFE), or the like) but not a hydrophilic material (glass fiber, nylon, cellulose, or the like).
  • a hydrophobic material e.g., polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, polystyrene, polyester, hydrophilic polytetrafluoroethylene (PTFE), or the like
  • PTFE hydrophilic polytetrafluoroethylene
  • the spacers 307a-d can be oriented in the same plane as the reaction segments 305a-c and can be oriented therebetween.
  • a solid phase LAMP reaction medium can include a spreading layer 308, and a reaction layer 306, joined by adhesive layer 304.
  • the material type of spacers 307a-307d can enhance or otherwise positively affect the degree of spreading.
  • polystyrene spacers can result in more spreading than other material types.
  • a solid phase reaction medium without a spreading layer 308 may simplify manufacturing at the cost of user simplicity. The user could apply the saliva sample to each of the test spots 305a-c individually in this case.
  • spacers of a material that repels or minimally absorbs the sample such as polystyrene can assist the spreading layer in providing uniform spreading results.
  • such spacers of such materials can also assist in spreading a sample when a spreading layer 308 is not used.
  • a method 400 of testing for a presence of a viral pathogen can comprise providing a saliva sample from a subject, as shown in block 410, and dispensing the sample into a test environment having a solid phase reaction medium in combination with a LAMP reagent mixture and a pH sensitive dye, as shown in block 420.
  • the method can comprise minimizing the amount of volatile agents, hygroscopic agents, and non-pH sensitive agents capable of discoloring the solid phase medium.
  • the method can comprise providing an amount of one or more target primers, DNA polymerase, and a re-solubilization agent sufficient to facilitate a LAMP reaction.
  • the method can comprise providing an amount of reverse transcriptase sufficient to facilitate an RT-LAMP reaction.
  • the method can comprise providing an amount of one or more target primers sufficient to detect the viral pathogen.
  • the method can comprise generating a test result in less than one hour after dispensing the sample into the test environment.
  • a method 500 of confirming suitability of a saliva sample for testing with a solid phase LAMP reaction can comprise providing a solid phase reaction medium with at least one test site or spot said at least one test site or spot including a combination of LAMP reagents and a pH sensitive dye.
  • the method can further comprise providing a solid phase reaction medium with at least one negative control site, said negative control site including a pH sensitive dye, and excluding LAMP reagents, as shown in block 510.
  • the method can further comprise applying the saliva sample to the solid phase reaction medium, as shown in block 520.
  • the method can further comprise confirming activation of the pH sensitive dye on the negative control site, as shown in block 530.
  • the pH sensitive dye can be at least one of phenol red, phenolphthalein, azolitmin, bromothymol blue, naphtholphthalein, cresol red, or combinations thereof.
  • the LAMP reagents can be substantially free of volatile reagents, pH-affecting reagents, magnesium-containing reagents, or combinations thereof.
  • the LAMP reagents can comprise non-interfering LAMP reagents including DNA polymerase, reverse transcriptase, primers for a target region, or combinations thereof.
  • the method can further comprise providing the test site or spot defined by at least two sections of discontinuous adhesive layers. In another example, the method can further comprise providing the test site or spot defined by at least three sections of discontinuous adhesive layers.
  • a method 600 of maximizing accuracy of a positive test result from a solid phase LAMP reaction can comprise providing a solid phase reaction medium with at least three test site or spots, each including a common pH sensitive dye and a combination of LAMP reagents, as shown in block 610.
  • each site can include a different primer sequence from a target pathogen.
  • the method can comprise initiating a LAMP reaction, as shown in block 620.
  • the method can comprise confirming a positive test result when at least two of the test site or spots activate the pH sensitive dye and experience a change from a first color to a second color, as shown in block 630.
  • the method can further comprise providing an amount of reverse transcriptase sufficient to facilitate an RT-LAMP reaction.
  • the pH sensitive dye can be at least one of phenol red, phenolphthalein, azolitmin, bromothymol blue, naphtholphthalein, cresol red, or combinations thereof.
  • the LAMP reagents can be substantially free of volatile reagents, pH-affecting reagents, magnesium-containing reagents, or combinations thereof.
  • the target pathogen can comprise a viral pathogen, a bacterial pathogen, a fungal pathogen, or a protozoa pathogen.
  • the target pathogen can comprise a viral pathogen.
  • the viral pathogen can comprise a dsDNA virus, an ssDNA virus, a dsRNA virus, a positive-strand ssRNA virus, a negative-strand ssRNA virus, an ssRNA-RT virus, or a ds-DNA-RT virus.
  • each primer sequence can match a sequence from a viral target comprising H1N1, H2N2, H3N2, HlNlpdmO9, or SARS-CoV-2.
  • the specific target nucleotide sequences to be detected can be target nucleotides corresponding to human biomarkers. Any disease that has a target nucleotide corresponding to a human biomarker for a disease can be detected.
  • Various types of diseases can be detected including one or more of: breast cancer, pancreatic cancer, colorectal cancer, ovarian cancer, gastrointestinal cancer, cervix cancer, lung cancer, bladder cancer, many types of carcinomas, salivary gland cancer, kidney cancer, liver cancer, lymphoma, leukemia, melanoma, prostate cancer, thyroid cancer, stomach cancer, the like, or combinations thereof.
  • biomarkers for various types of diseases can be detected by detecting target nucleotides corresponding to one or more of: alpha fetoprotein, CAI 5-3 and CA27-29, CA19-9, C! -125, calcitonin, calretinin, carcinoembryonic antigen, CD34, CD99MIC 2, CD117, chromogranin, chromosomes 3, 7, 17, and 9p21, cytokeratin, cesmin, epithelial membrane antigen, factor VIII, CD31 FL1, glial fibrillary acidic protein, gross cystic disease fluid protein, hPG80, HMB-45, human chorionic gonadotropin, immunoglobulin, inhibin, keratin, lymphocyte marker, MART-1, Myo DI, muscle-specific actin, neurofilament, neuron-specific enolase, placental alkaline phosphatase, prostate-specific antigen, PTPRC, SI 00 protein, smooth muscle action, synaptophysin,
  • the positive control can include a synthetic DNA target as one of the test sections to confirm that the DNA template is stable.
  • the negative control can include: (a) enzyme reagents without primers, or (b) enzyme reagents with primers that are targeted to a distinct virus.
  • test sections can be used to achieve an enhanced coverage of different viral strains (e.g., SARS-CoV-2).
  • the timing and limit of detection can be selected for each primer.
  • 97% coverage of a virus e.g., SARS- CoV-2
  • including 2 additional primers that are slower and less sensitive compared to the first primer may not enhance the coverage for the virus.
  • the plurality of test sections can be used to achieve coverage of different viral pathogens (e.g., SARS-CoV-2, H1N1, H2N2, H3N2, HlNlpdmO9, and the like).
  • LAMP testing on a solid-phase medium can be enhanced in several ways.
  • the test environment can be monitored to prevent variations that might impact the testing process.
  • the storage conditions of the biological sample testing apparatus can impact the validity of the biological sample testing apparatus. When these conditions are tightly monitored, the biological sample testing apparatus can have enhanced operability in comparison to liquid-based LAMP tests.
  • a method of testing for a presence of a target nucleotide sequence can comprise: providing a biological sample, as shown in block 710, and dispensing the sample into a test environment having a solid-phase reaction medium in combination with a loop-mediated isothermal amplification (LAMP) reagent mixture and a pH sensitive dye, as shown in block 720.
  • the method can comprise providing an amount of reverse transcriptase sufficient to facilitate an RT-LAMP reaction.
  • the type of biological sample can affect the test environment. For example, a saliva sample can have a buffering capacity that can reduce the contrast of the test output.
  • the biological sample can be at least one of: saliva, mucus, blood, urine, sweat, exhaled breath condensate, or feces.
  • the method can further comprise collecting the biological sample using one or more of a saliva collection device, a nasal swab, a blood collection device, a urine collection device, a sweat collection device, an exhaled breath collection device, or a stool collection device.
  • the test environment can be controlled to provide consistent test outputs.
  • the test environment can be substantially free of volatile reagents, pH-affecting reagents, drying agents, or combinations thereof. Each of these reagents can reduce the consistency of the test results by introducing variables that might be compensated for with additional analysis.
  • test environment variable that can be monitored is the rate that the temperature increases when the biological test apparatus is used to heat the biological sample.
  • the method can comprise raising a test environment temperature at a rate of about 0.1°C per second.
  • test environment temperature can be raised at a rate of about 0.1 °C per second to about 0.2 °C per second.
  • the reverse transcriptase can be activated at about 55 °C and the DNA polymerase can be activated at about 65 °C. Consequently, a ramp rate higher than about 0.2 °C per second can interfere with the the coordinated action of reverse transcriptase and DNA polymerase in a LAMP reaction.
  • the ramp rate can be raised until the test environment temperature is in a range from about 60 °C to about 67 °C.
  • the test environment is increased to about 55 °C (i.e. the temperature at which the reverse transcriptase can be activated)
  • a ramp rate of about 0.1 °C from 55 °C to about 65 °C
  • the biological sample test apparatus can provide invalid results. Therefore, the ramp rate should be monitored not just in the testing environment temperature range from about 55 °C to about 65 ° C, but also as the biological sample is being heated to about 55 °C.
  • the variability of the testing environment can also affect the results from the biological sample test apparatus.
  • the method can comprise providing a heating uniformity in the testing environment that has a variability of less than 1°C.
  • the spatial variability of the temperature around the testing cartridge should not be greater than about 0.5 °C to avoid interference with the LAMP reaction.
  • the method can comprise a testing time of from about 15 minutes to about 30 minutes for a saliva sample.
  • the method can comprise a testing time of from about 30 minutes to about 45 minutes for a saliva sample.
  • the method can comprise a testing time of from about 45 minutes to about 60 minutes for a saliva sample.
  • the method can comprise a testing time of from about 60 minutes to about 90 minutes for a saliva sample. In another aspect, the method can comprise a testing time of from about 20 minutes to about 30 minutes for a nasopharyngeal sample. In another aspect, the method can comprise a testing time of from about 30 minutes to about 40 minutes for a nasopharyngeal sample.
  • the method can further comprise providing a solid phase reaction medium comprising glass fiber, nylon, cellulose, polysulfone, polyethersulfone, cellulose acetate, nitrocellulose, hydrophilic PTFE, the like, or combinations thereof.
  • the solid phase reaction medium can comprise a material as otherwise disclosed herein.
  • the target nucleotide sequence can be from at least one of a viral pathogen, a bacterial pathogen, a fungal pathogen, or a protozoan pathogen.
  • the target nucleotide sequence can be from a viral pathogen.
  • the viral pathogen can be from the group consisting of: Coronoviridae, Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Adenoviridae, and Parvoviridae.
  • the viral pathogen can be selected from the group consisting of: severe acute respiratory syndrome coronavirus (SARS-CoV-1), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome (MERS), influenza, and H1N1.
  • the target nucleotide sequence can be from a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen.
  • the test accuracy of the biological sample testing apparatus can be affected by the length of storage before testing and the storage conditions (e.g., storage temperature, humidity, and the like).
  • a biological sample testing apparatus can comprise a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye.
  • LAMP loop-mediated isothermal amplification
  • the apparatus can provide a degree of test accuracy of at least about 95%, 96%, 97%, 98%, or 99% after storage for 6 months when stored at a selected temperature (e.g., room temperature of about 25 °C).
  • the apparatus can provide a degree of test accuracy of at least about 95%, 96%, 97%, 98%, or 99% after storage for 12 months when stored at a selected temperature. In another aspect, the apparatus can provide a degree of test accuracy of at least about 95%, 96%, 97%, 98%, or 99% after storage for 2 years when stored at a selected temperature. In another aspect, the apparatus can provide a degree of test accuracy of at least about 95%, 96%, 97%, 98%, or 99% after storage for 3 years when stored at a selected temperature. In another aspect, the selected temperature can be any temperature in a range between about - 20 °C and about 37 °C.
  • the biological sample testing system can include a housing.
  • a biological sample testing system can comprise: a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye, said housing operable to receive a biological sample.
  • the biological sample testing system can further comprise a heater configured to isothermally heat the container to an internal temperature sufficient to initiate and sustain a LAMP reaction between the LAMP reagent mixture and a biological sample for a time used to generate a test result via the pH-sensitive dye.
  • the substrate can comprise an optically transparent material.
  • the substrate can engage the solid phase reaction medium via an adhesive.
  • the adhesive can be substantially optically transparent.
  • the substrate can comprise a portion of a housing.
  • the biological sample testing system can further comprise an adhesive layer disposed on the substrate, a reaction layer disposed on the adhesive layer, and a spreading layer disposed on the reaction layer.
  • the biological sample testing system can further comprise a spacer layer oriented in the same plane as the reaction layer.
  • the biological sample testing system can further comprise a housing disposed against the substrate.
  • the housing can be further disposed against the spreading layer.
  • the housing can substantially enclose the substrate, adhesive layer, reaction layer, and spreading layer.
  • an operation for a biological testing system can include: (a) using the sponge to collect saliva, (b) plunging the sponge into a collection tube, (c) diluting the collection tube with water to dilute the saliva sample down to 5% to stabilize the saliva pH and to reduce the buffering capacity of the saliva, (d) transferring the saliva sample to the test strip which in the cartridge using a pipette by applying the saliva sample to a single location so that a capillary and a mesh layer can spread the saliva sample to the discrete segments of the reaction layer; (e) putting the cover onto the cartridge and locking the cover in place; (f) verifying that the pH of the saliva sample is within a testing range by examining the segments of the reaction layer; (g) inserting the cartridge into the heater, and (h) verifying the proper positioning of the cartridge within the heater; (i) activating the heater; (j) reading the results after about 30 minutes when the testing has been completed; (k) determining whether the results are valid
  • Operation (a) can be performed by collecting the saliva via a sponge-collection device or a passive drool device.
  • a sponge-collection device When a sponge-collection device is used, the sponge can be plunged into the collection tube to release the saliva into the collection tube (operation (b)).
  • the collection tube can be diluted with water to decrease the buffering capacity of the saliva, reduce the viscosity of the saliva, and allow for an increased uniformity in the sample (operation (c)).
  • the saliva sample when transferred to the test strip, can be individually applied to each section of the test strip or can be applied to the center of the test strip with the spreading layer spreading the sample throughout the testing area of the test strip (operation (d)).
  • the test strip can be covered to avoid contamination with the test environment (operation (e)).
  • the pH of the saliva sample can be tested through various means such as a colorimetric device, a fluorescent reader, or by a simple comparison with a pH color chart for the pH indicator in use (operation (f)).
  • the cartridge can be placed into the heater and activated (operations (g), (h), and (i)) with the time recorded in order to measure the total reaction time and time to reach a positive or negative result.
  • the results can be read after 30 minutes (operation (j)), or the results can be read as soon as the results show a positive result.
  • the speed with which a positive result appears can be correlated to the concentration of the pathogen.
  • the results can be determined to be valid (operation (k)) based on the positive controls, negative controls, other pathogen results, or a combination thereof.
  • the results can be determined to be positive or negative, when a pH-based indicator is used, by comparing the color of the results with a color comparison chart for the pH-based indicator.
  • the results can also be determined to be positive or negative by measuring the wavelength
  • a biological testing kit can comprise one or more of a saliva collection device, a collection tube, a cartridge, a pipette, a heater, a color chart, or combinations thereof, as illustrated in FIGS. 8a and 8b.
  • the saliva collection device can be a sponge-collection device or a passive-drool device.
  • a user can collect saliva using one or more operations including: (a) removing a Pure-SalTM from a pouch of a biological testing kit, (b) placing the sponge of the Pure-SalTM to collect saliva until the indicator changes color or some other indication is provided that shows the end of the saliva collection process, (c) securing the collection tube into a compression tube, (d) inserting the sponge sampler into the compression tube, (e) compressing the sponge to squeeze the collected saliva (without some of the degradative saliva enzymes) into the compression tube, (I) closing the tube, and (g) mixing the tube by inverting a number of times (e.g., 1 to 10 times).
  • the user can prepare the cartridge, as illustrated in operation 2 from FIG. 8a.
  • the user can (i) remove the test from the foil pouch, (ii) remove the sheath from the cartridge, and (c) place the cartridge on a level surface.
  • the user can also transfer the sample, as illustrated in operation 3 from FIG. 8a, by filling the pipette to the black line with diluted saliva (e.g., diluted with water), and transferring into the sample well.
  • the user can also seal the cartridge, as illustrated in operation 4 from FIG. 8a, by placing the sheath onto the cartridge such that the clips align and snap together.
  • the user can also heat the cartridge, as illustrated in operation 5 in FIG. 8a, by placing the cartridge into the accessory heater, closing the lid and initiating the accessory heater, which can indicate via LEDs when a reaction has been completed.
  • a user can remove the cartridge from the heater and compare the cartridge to a color chart while also ensuring that the orientation between the color chart and the cartridge is correct.
  • a color chart as illustrated with reference to the viral pathogen SARS- CoV-2, can include 6 squares in 2 rows and 3 columns.
  • a first column can (-ve) can indicate a negative result
  • a second column (+ve) can indicate a positive result
  • a third column invalid test
  • the first column can indicate a negative result because both the top row square and the bottom row square are approximately a red-orange color, which can occur when nucleotide amplification for a LAMP reaction does not occur in either square.
  • the second column can indicate a positive result because the top row square is approximately a red-orange color, which can occur when nucleotide amplification for a LAMP reaction does not occur, but the bottom square is approximately an orange-yellow color, which can occur when nucleotide amplification for a LAMP reaction occurs, and indicates that the viral pathogen was present.
  • the third column can indicate an invalid result because the top row square is approximately an orange-yellow color, which can occur when nucleotide amplification for a LAMP reaction occurs, but the bottom square is approximately an orangeyellow color, which can occur when nucleotide amplification for a LAMP reaction occurs. But for the third column, the reason for the color change from the red-orange color to the orange-yellow color can be inconclusive because the negative control (e.g., the top row) also changed color.
  • a user can compare the color chart to the test in the cartridge to determine a test result.
  • the color chart illustrated in FIG. 8b is one example.
  • the color chart can include additional rows or columns to accommodate any number of tests for additional controls, additional pathogens, or different primers directed to the same pathogens.
  • the test can be self-administered by the subject, or can be administered by a trained technician, a nursing assistant, a nurse, a physician assistant, a medical doctor, or any other person qualified to administer the test and interpret the results.
  • the paperbased LAMP assembly comprised: (i) a reading layer, (ii) 2 reaction strips, and (iii) a spreading layer.
  • the reading layer comprised a transparent 3 millimeter Melinex® backer for support.
  • the Melinex® backer was attached to the 2 reaction strips, which were each formed of 5 mm x 20 mm chromatography paper (e.g., Whatman® Grade 1 chromatography paper) contacted by a double-sided adhesive (ArClean® 90178).
  • the two test strips were separated by 2.5 x 20 mm 10-millimeter polystyrene spacers to prevent cross-talk between the two test strips.
  • the spreading layer comprised a polyester sulfone mesh (Saaticare® PES 105/52). The sample was loaded on the spreading layer.
  • FIG. 9 shows an example of the assembly.
  • Paper-based materials were selected based on five criteria: (a) stability of formulation when dried on the substrate, (b) intensity of color change when rehydrated with sample, (c) ability of the sample to evenly wick throughout the paper-based substrate, (d) ability of the material to remain inert throughout the reaction, and (e) ability of the paper-based material to demonstrate a color change upon amplification. Whatman® Grade 1 chromatography paper was tested and used for optimization. When assembling two test strips together, it was observed that the distribution of fluid was uneven because the LAMP reaction used a large area of the Grade 1 chromatography.
  • a chromatography paper that is thicker than the Grade 1 chromatography paper e.g., Ahlstron Grade 222 chromatography paper
  • the test strips to be about 5 mm x 6 mm in surface area while also carrying the same amount of sample and reagents as the Grade 1 chromatography paper, which allowed greater uniformity of spreading during rehydration.
  • EXAMPLE 3 Material Screening - Grade 1 and Grade 222 Chromatography Paper
  • the images illustrate examples of the color contrast that can be generated.
  • grade 1 chromatography paper was used.
  • grade 222 chromatography paper was used.
  • RT-LAMP reagents were dried and rehydrated with 25 pL of 5% saliva and 95% water.
  • the positive samples contained heat-inactivated SARS-CoV-2 spiked in at 10k copies per reaction, and negative samples were 5% saliva (without virus) and 95% water.
  • the images were captured at the 90-minute time point incubation at 65 °C.
  • the color contrast between the negative result for grade 1 paper and the positive result for grade 1 paper is less pronounced than the color contrast between the negative result for grade 222 paper and the positive result for grade 222 paper. Therefore, the thicker paper produced enhanced color contrast.
  • a paper assembly protocol can include: (1) cut out polyethylene terephthalate (PET) into rectangles having dimensions of 80mm x 7mm to create 2 per device; (2) cut out chromatography paper into rectangles having dimensions of 33mm x 5mm to create 1 per device; (3) cut out a large sheet of double-sided tape and tape the PET rectangles onto it so that there are 2 cm in between each PET rectangle; (4) cut out all of the rectangles so that there is extra tape on all sides; (5) peel off the tape with the PET on it and tape the chromatography paper on the opposite side of the PET leaving about 1 cm outside the tape; (6) add 25 ul of sample onto the chromatography paper by using a single spot that is close to the inside of the device; (7) tape the other PET strip to cover the sample (i.e.
  • the side with the tape should touch the sample and the PET should be on the outside); (8) fold any tape that is sticking out onto the PET tape to further seal; (9) add 1 ml of solvent to the bottom of a 15 ml tube; (10) put the assembled paper device in the tube so that the chromatography paper sticking out is in the solvent; (11) close the tube; and (12) incubate at 65 °C for 1 hour.
  • An LoD study used a primer set targeted for various regions of SARS-CoV-2 and 2- fold serial dilutions of heat-inactivated SARS-CoV-2 at concentrations of 2.5, 5, 10, 20, and copies/pL in a reaction volume of 25 pL.
  • the estimated LoD was about 20 copies/pL with 4/4 replicates showing a change of color from red to yellow, therefore confirming that amplification occurred.
  • the LOD for a liquid-based LAMP reaction can be a concentration of about 20 copies of virus per pL of sample volume.
  • a solid-phase reaction medium e.g., chromatography paper
  • each reaction area can hold a sample volume of about 25 pL.
  • the color of the reaction mixtures at different time points were recorded by scanning the plate on a tabletop scanner (Epson® Perfection V800 Photo Color).
  • the LoD for a primer set was determined by the lowest viral concentration that resulted in a strong color change in all three replicates. Any candidate that was able to provide amplification at 10 3 copies/reaction or lower was then subjected to the same procedure with virus dilutions (e.g., diluted by factors of 2x) and spiked into pooled, healthy saliva to check for matrix interference. Saliva LoD studies were then conducted on the paper-based device to check for primer compatibility on a paper substrate.
  • the reactions on the right were conducted in liquid using heat-inactivated SARS-CoV-2 spiked into water with a colorimetric mixture combined with a fluorescent dye using a rection volume of 25 pL.
  • the black lines indicated a color change as measured by the absorbance ratio (OD430/OD560) and the light blue lines indicated a fluorescent change as measured by the fluorescence intensity in units of 10 3 .
  • the time of detection could be faster when used with a built-in color/fluorescence reader.
  • the absorbance ratio and fluorescent activity never spikes as expected.
  • the sensitivity and specificity were determined using 30 contrived positive samples at varying multiples of the LoD (lx, 2x, 4x, 40x, and 400x with 10, 10, 4, 3, and 3 replicates, respectively) and 30 non-template control (NTC) negative saliva samples.
  • the colorimetric response intensity was determined using ImageJ to extract the average green channel intensity of each reaction zone.
  • a receiver-operating characteristic (ROC) curve was generated by varying the threshold cutoff between positive and negative reactions and calculating the sensitivity and specificity at each threshold value.
  • the sensitivity was calculated as a ratio of the number of true positives to total positives, including false positives.
  • the specificity was calculated as a ratio of true negatives to total negatives, including false negatives.
  • FIG. 12 illustrates a paper strip format.
  • the black lines indicate SAATICARE Hyphyl® Polyester PES 105/52 having a thickness of 0.063 mm and a length of 50 mm.
  • the red lines indicate Tekra Clear MELINEX® 454 Polyester PET having a thickness of 0.0762 and a length of 50 mm.
  • the green lines indicate Adhesives Research ARclean® 90178 (AS- 144) having a thickness of 0.038 mm and a length of 50 mm.
  • the orange block indicates Tekra Double White Opaque High Impact Polystyrene Litho Grade having a thickness of 0.508 mm and a length of 2.5 mm.
  • the blue block indicates Ahistrom-Munksjo Cellulose Grade 222 having a thickness of 0.83 mm and a length of 5 mm.
  • the paper strip has 5 spacers (in orange) and 4 reaction layer sections (in blue), along with a spreading layer (in black), an adhesive layer (in green), and a substrate (in red).
  • a solid phase LAMP reaction medium can include: a 6 mm x 50 mm clear 3 mm Melinex® 454 with Arclean® 90178; a reaction layer comprising 5 mm Ahlstrom 222 reagent material (including 4 discontinuous reaction layer sections in pink); spacers comprising 2.5mm 20 mil polystyrene (including 5 discontinuous spacers), a spreading layer comprising Saaticare® PES 105/52 hyphyl, and a substrate comprising a capillary created with 14 mm Melinex, Arclean® 90178, and 3M 9962.
  • cross talk between reaction zones can be avoided by having sufficient space between each reaction section or test area.
  • the four reaction sections in orange remain free from cross-contamination because the 5 spacers are free of color changes.
  • grade 222 chromatography paper can provide greater contrast than grade 1 chromatography paper.
  • the positive results for the 222 paper show a greater contrast between the positive results on the top left (yellowish orange) and the negative results on the bottom left (dark orange) compared to the positive results for the on the top right (orange) and the negative results on the bottom right (dark orange).
  • Each paper strip was tested with about 500 /rM of buffer with a pH ranging from 8.0 for the negative test to 7.5 for the positive test.
  • FIG. 15B illustrates RT-LAMP when incorporating drying at different starting pH of the RT-LAMP reaction mixture.
  • pH 7.6 is the unadjusted pH of the RT- LAMP reaction mixture.
  • Dried setup indicated paper strips were left to dry for 30 minutes at room temperature after applying 20 pL LAMP master mix and then rehydrated with 25 pL synthetic RNA (‘+’) or water LAMP reactions contained 12.5 pL NEB 2x colorimetric master mix, 2.5 pL of primer mix, and 5 pL of phenol red prepared in nuclease-free water (1 mM). The pH of the resulting mix was adjusted with KOH. Grade 1 chromatography paper was used. Heating was carried out in an incubator set at 65 °C for 120 minutes and scanned with a flatbed scanner at time points of 45, 60, 90, and 120 minutes during the reaction.
  • a test strip format has a sample application side and a read side (top right of the Figure).
  • the sample can be applied to the sample application side in one position when the spreading layer is present. In other examples, without a spreading layer, the sample can be applied to the sample application layer over each section of the reaction layer (orange).
  • the read side can be read without specialized instrumentation or with a colorimetric detector or fluorescent detector.
  • the test strip format also has 4 test reaction areas, an absorbent/ spreading layer, and clear single-sided adhesive that will conform to shape and contact the absorbent layer.
  • FIG. 17 illustrates a test strip assembly process including slitting in which the reaction layers are coated in wider widths and slit to 5 mm and placed on reels for lamination.
  • the process also includes a first lamination process of reaction layers to clear single-sided adhesive.
  • the process also includes a second lamination process that is performed in line directly after the first lamination process, and wherein the spreading layer is laminated to the reaction layer and the adhesive layer.
  • the test strip assembly process can comprise materials including polysulfone material coated with pH reagent, a single-sided adhesive, and chromatography 1 paper.
  • RNA from the SARS-CoV-2 virus in saliva was extracted, reverse-transcribed, and amplified in a one-pot mixture by heating the saliva and reagent mixture at 65 °C.
  • the four primer sets used for LAMP include: one targeting the SARS-CoV-2 RdRp gene, one targeting the SARS-CoV-2 envelope gene (E), one targeting the SARS-CoV-2 ORFlab region, and finally one targeting the human RNaseP (RP) gene which serves as an on-board control.
  • Each primer set was comprised of 6 individual primers, targeting specific regions of viral or human RNA which are reverse-transcribed and amplified during isothermal incubation using a reverse transcriptase and a strand-displacing polymerase.
  • a positive control reaction is included on-board the test device as one of the test regions which is run together with the three test strips for viral RNA.
  • the positive control simultaneously serves as a positive template control and extraction control. If a red-to-yellow color change occurs on the control region of the test strip, this indicates that viral RNA, if it were present in the specimen, has been successfully extracted from the virus, and that the reagents in the test are all performing as expected in order to produce an amplification signal. If the color change does not occur, then the test should be considered invalid and repeated.
  • the positive control detects human RNase P, a ubiquitous marker in human clinical specimens and a standard control in many RT-PCR kits. Amplification of this marker indicates that lysis of human cells has successfully occurred under the test conditions, and that viral lysis can also be inferred.
  • a negative, no template control test is performed by using the test device with a blank test solution in lieu of a saliva specimen.
  • the blank test solution is a sterile, pH-buffered solution without any RNA or DNA template. If a color change were observed in this test, it would suggest a likelihood of false positives and therefore invalidate any positive results obtained since the last control was run. Therefore, instructions to the user will have the user site perform this negative control upon receipt of the test kits using one such representative test kit. This confirmation can also be repeated at a defined interval.
  • the most likely cause of false positives in a negative control is carryover of amplified DNA product from sequential tests.
  • the negative-control test is the last in a line of control measures to prevent false-positives due to carryover contamination, including manufacturing controls of cartridges with tight seal tolerances and routine disinfecting wipe-cleaning of the heater apparatus by the operator.
  • the test assembly employs a unique control designed for the use of saliva as the test substrate.
  • Each test strip includes pH indicator dye which serves as an internal control that validates that the initial pH of the saliva specimen is within the expected range. If a color change from red to yellow is observed on all four test strips when the sample is applied (prior to heating), then the user should conclude that the specimen is invalid and not proceed with the test. External factors such as eating, drinking, or use of oral hygiene products prior to sampling can skew the initial pH of the specimen. In the presence of a failed pH indicator, if the operator determines that one of these factors has affected the specimen, then a re-test can be performed after allowing 5 minutes for the patient’s saliva pH to return to their normal state. Other external factors such as some forms of illness can also systemically affect saliva pH, in which case use of an alternative testing means is indicated. EXAMPLE 18 - Result Confirmation
  • the Paper LAMP test is a qualitative test.
  • the test is a color-based visual result that can be read by the operator with the aid of an interpretative color chart. A positive reaction result yields a yellow color. All test controls should be examined prior to interpretation of patient results. If the controls are not valid, the test is invalid and patient results cannot be interpreted.
  • the presence of the target SARS CoV-2 RNA at levels defined by the LoD experiments will produce results indicative of a positive test.
  • a positive test interpretation may be confirmed by a positive result in 2 of the 3 target gene primer regions of Orflab, E Gene or RdRp Gene.
  • the color of the test strip can be compared to a supplied color interpretation chart to identify positive results.
  • the RNaseP region of the test strip should turn yellow to indicate a valid test. If that region does not turn yellow the test is invalid and should be repeated.
  • the first indicator of a reliable and legitimate test strip is the confirmation that the 4 test strip regions do not turn yellow upon application of the saliva before heating of the test strip. If this occurs the saliva pH is outside an acceptable range likely due to recent food or fluid intake. The patient should rinse their mouth with water, wait at least 5 minutes, and resample the saliva.
  • the on-board control should show a positive yellow color change in the RNaseP region. Once that has been confirmed then each strip region should be examined for color change versus the supplied color interpretative chart. Each strip region is classified as positive (e.g., a yellow change) or negative (e.g., pink color). In one example, a confirmation of SARS CoV-2 can be indicated when 2 of the test regions are positive.
  • False positives can often occur in RT-LAMP assays if proper care is not taken to address them in assay procedure. Sources of these false positives can stem from DNA aerosols formed by previous RT-LAMP reactions that remain in the environment for extended periods of time and that contaminate future experiments. These aerosols can either contaminate individual reagents during reaction prep or contaminate reaction mixtures when they are being transported, handled, loaded with samples, or incubated. Aside from reducing the accuracy of RT-LAMP related tests, aerosols can add noise to experiments that use specific concentrations of template, such as LoD studies. To address these various points of contamination, all RT-LAMP related procedures can be separated into stages (i.e.
  • reaction preparation transport, loading/sealing, incubation for amplification, and gel electrophoresis
  • transport By spatially separating operations in the protocol, the likelihood of aerosols being introduced before reaction sealing can be minimized or troubleshooted if false positives occur.
  • FIG. 22A shows colorimetric RT-LAMP scan images for the limit of detection (LoD) of orflab.II.
  • LoD limit of detection
  • Titles of scans are catalog numbers that correspond to different plate types that were used to run colorimetric LoD. Yellow wells indicate a successful LAMP reaction taking place whereas red/orange wells indicate absent or low-level amplifications respectively.
  • 20 pL reaction mixtures were spiked with 5 pL of heat-inactivated virus dilutions in water at the labeled concentrations.
  • Reaction master mixes consisted of 12.5 pL of NEB Colorimetric 2x master mix, 2.5 pL of primer mix, and 5 pL of water. Endpoint images were taken after heating in an incubator set at 65 °C for 60 minutes. Three replicates for each viral concentration were run per primer set.
  • FIG. 22B shows colorimetric RT-LAMP scan images for limit of detection (LoD) of orflab.II.
  • LoD limit of detection
  • Titles of scans are catalog numbers that correspond to different cap types that were used to run colorimetric LoD. Yellow wells indicate a successful LAMP reaction taking place whereas red/ orange wells indicate absent or low-level amplifications, respectively.
  • 20 pL reaction mixtures were spiked with 5 pL of heat-inactivated virus dilutions in water to result in the final labeled concentrations (positive reactions) or nuclease-free water (negative).
  • Reaction master mixes included 12.5 pL of NEB Colorimetric 2x master mix, 2.5 pL of primer mix, and 5 pL of water. Endpoint images were taken after incubating the plate at 65 °C for 60 minutes. Three replicates for each viral concentration were run per primer set.
  • a fully assembled, 4-plex test strip can include a spreading mesh, adhesive, and see- through Melinexbacker.
  • the test strip can also include a DNA template in water at a concentration of 0.2 ng/uL which corresponds to about 10 8 copies/uL.
  • the sample volume can be 100 uL.
  • An N-gene primer can be used with alternating conditions of primers and noprimers.
  • the adhesive might have a buffering effect that inhibits color response so the formulation should be to compensate.
  • the Paper LAMP test is designed for simple point of care use by trained healthcare professionals. The entire testing process is described in FIG. 18.
  • the patient collects a saliva specimen under the guidance of the healthcare professional.
  • the saliva sample is collected into a specialized collection vessel which contains no additives and is thus safe for the patient to use in the collection.
  • the volume of saliva is approximately 100 pL, which is easily collected by the patient.
  • the test strip which contains the specific RNA detection regions as noted above is entirely contained in a plastic strip holder. After collection of the saliva sample the patient hands the collection vessel to the operator. The operator then applies the saliva sample to the test strip at the indicated locations and closes the cartridge housing.
  • the cartridge with the strip which contains the sample is then placed in the heater apparatus which is designed to securely hold the cartridge in place to achieve the desired heating to 65 °C.
  • the Paper LAMP assay proceeds on the test strip at an isothermal temperature.
  • the nucleic acids are identified in the saliva sample and, under a temperature of 65 °C, the resulting change of pH from the amplification of nucleic acids causes a color change on the strip.
  • the heater apparatus is designed to provide uniform heating across the test strip.
  • the heating apparatus can have (red-yellow-green) colored LED lights to show the user the progress of the heating in terms of time of incubation and alert the operator when the test has reached conclusion.
  • the heater apparatus can contain a feature, e.g., a magnetic or mechanical lock to ensure the test is not interrupted.
  • the test reaction can proceed for approximately 15 to 30 minutes at the isothermal 65 °C temperature.
  • the test carrier with the test strip contained therein can be removed from the heater and visually read.
  • FIG. 18B illustrates fabrication and use of a paper-based colorimetric molecular test for SARS-CoV-2.
  • the fabrication of the paper-based colorimetric molecular test for SARS- CoV-2 includes: (la) Creating a master mix, (lb) transferring the mix to a pad, (1c) performing a quality check, and (Id) air drying the test device.
  • the use of the paper-based colorimetric molecular test for SARS-CoV-2 includes: (2a) sample collection, (2b) resuspension in water, (2c) adding the sample to the pad, (2d) incubation for about 60 minutes at 65 °C, and (2e) interpreting the results.
  • FIG. 19A The workflow of the assay is illustrated in FIG. 19A: collect saliva, transfer sample to paper-based device, incubate at 65 °C, and read a result; a typical result is shown in FIG.
  • FIG. 19C provides a schematic of our paper device’s structure.
  • the paper device included several Grade 222 cellulose reaction pads separated by 20 mil polystyrene spacers to prevent crosstalk between reaction zones. These components were attached to a transparent backing for structural support via a double-sided adhesive. Reagents to conduct RT-LAMP were dried onto the reaction pad during fabrication. These reagents were rehydrated when the user added the sample to the reaction zones.
  • FIG. 19 illustrates schematics and colorimetric characterization of the paper-based device.
  • FIG. 19A provides a schematic illustration of the workflow for device use. The control zone indicates the no-primer control.
  • FIG. 19B provides colorimetric LoD on paper using heat-inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the indicated concentration in 5% saliva. The negative replicates are RT-LAMP reactions using nuclease-free water in lieu of heat-inactivated SARS-CoV-2. Data was taken from FIG. 21A.
  • SARS-CoV-2 heat-inactivated severe acute respiratory syndrome coronavirus 2
  • FIG. 19C provides a schematic layout of the paper device.
  • FIG. 19D provides typical colorimetric results of a negative and positive run. Controls are RT-LAMP reactions without LAMP primers included. Positive reactions have 800 copies/pL spiked into 5% saliva.
  • FIG. 19E provides a color gradient of possible results derived from the colorimetric results of panel B.
  • FIG. 19F provides a summary table of observations used to calculate the analytical sensitivity and specificity of the paper device based on survey responses.
  • Each operation of the assay was designed to reduce complexity and mitigate user errors in point-of-care settings.
  • the sample collection operation uses a spongebased collection device which allows for self-collection by the patient, removes particulates from the collected saliva, and minimizes variance in results from patient to patient.
  • the transfer operation involved placing 25 pL of diluted saliva onto each of the two reaction zones on the device.
  • the paper device with the sample loaded is sealed in a resealable plastic bag and placed in an incubator set at 65 °C for 60 minutes.
  • the user compared the color of the control and reaction zones to the color bar in FIG. 19C to determine if the results are valid and if the pathogen of interest is present.
  • the platform comprises three main components: primer sets imposing specificity to the assay, a paper device containing two reaction zones (one control and one reaction), and a heating source used to heat the paper device to reaction temperatures.
  • the primer sets determine what pathogen the assay targets. Therefore, the platform can be reconfigured to target a different pathogen by redesigning the primer sets while keeping all other aspects of the device and formulation the same. Additionally, the paper-based device can be configured to accommodate numerous reaction zones allowing for multiple targets to be detected simultaneously.
  • the device had dimensions of 6 mm x 20 mm and included: a reading layer, two reaction strips, and spacers to prevent crosstalk.
  • the reading area included an optically clear 3 mil MELINEX (Tekra MELINEX® 454 Polyester (PET)) backer for support.
  • MELINEX Tekra MELINEX® 454 Polyester (PET)
  • PET Polyester
  • the strips were separated by 2.5 x 6 mm 20 mil polystyrene spacers (Tekra Double White Opaque High Impact Polystyrene (HIPS) Litho Grade). 25 pL of sample was added to saturate the strips when rehydrating.
  • HIPS Double White Opaque High Impact Polystyrene
  • a color bar was created by averaging RGB values of phenol red on Grade 222 chromatography paper over a range of pH values. A linear gradient was created using these average RGB values and the optimal threshold value determined from the ROC curve was annotated on the color bar (FIG. 19 C).
  • the device After loading the sample onto the paper-based device, the device was placed into a l” x 1” re-sealable plastic bag to prevent contamination during the RT-LAMP reaction.
  • the plastic bag containing the paper device was then placed into an incubator at 65 °C for 60 minutes.
  • the bag was removed, scanned with a flatbed scanner (FIG. 19D), and compared against a color chart (FIG. 19E) created by averaging RGB values from the phenol red response on grade 222 pads in buffers at known pH values from 6 - 9 (FIG. 21B).
  • the threshold value in the color chart corresponds to the threshold determined from ROC analysis (FIG. 19B).
  • FIG. 20 illustrates digital analysis of colorimetric responses on paper.
  • FIG. 20A shows a box plot for the green channel intensity of 30 positive and 30 negative results of RT-LAMP on paper.
  • FIG. 20B shows a receiver-operator (ROC) curve for 30 positive and 30 negative results of RT-LAMP on paper.
  • FIG. 20C shows a summary table for the observations based on image analysis.
  • Colorimetric perception surveys were collected from participants enrolled in the study in accordance with Purdue University IRB Protocol # IRB- 2021-375. Participants were given a color bar with a threshold annotated (FIG. 19E). Participants were given multiple paper device scans and were asked to classify the control pad (left reaction zone) as valid or invalid and the SARS-CoV-2 reaction (right reaction zone) as positive or negative. Observations classified as invalid were discarded from assay performance analysis and the proportion of incorrectly identified invalid assays was reported as the false invalid rate.
  • the standard time from saliva collection to test strip application is within 2 hours.
  • Sample stability with an allowance for testing for up to 24 hours from the sample collection can be based on repeat testing of samples (e.g., 15 positives and 15 negatives) at 0-2 hours, 8- 12 hours, and 20 - 24 hours.
  • Samples collected from patients in a rapid manner in a collection center or clinic setting can then be tested hours later.
  • Collection at one site e.g., in an outpatient facility or in a drive-thru collection area with subsequent transport of the saliva specimen to second location such as a location
  • Collection at one site e.g., in an outpatient facility or in a drive-thru collection area with subsequent transport of the saliva specimen to second location such as a location
  • test strip was designed so that it can be manufactured at scale on existing converting equipment without significant tooling costs. The design is simple enough to meet the goal of a fast and simple path from prototyping to full-scale production to meet the emerging market needs.
  • Paper is widely used in pH indicators and urine strips primarily due to the inexpensive cost, low technical complexity, and ease of production using roll-to-roll manufacturing.
  • Chromatography paper can be used in paper-based biosensors due to its improved wicking ability compared to other papers.
  • Many paper-based devices use Grade 1 chromatography paper; however, due to the large area (5 mm x 20 mm) of the Grade 1 chromatography paper, the distribution of solution across the paper was uneven.
  • Grade 222 (0.83 mm
  • Grade 222 is approximately 4.6 times thicker than Grade 1 (0.18 mm). Due to its increased thickness, the same volume of liquid can be loaded onto a 70%smaller reaction area by reducing the size of the device (5 mm x 6 mm), allowing for even distribution.
  • the components of the RT-LAMP reaction were dried on the paper. Drying allows for stable distribution of the device and easy operation without compromising diagnostic performance; the user simply adds the sample to rehydrate the reagents. Upon drying the reagents on paper, the papers changed color from red to yellow over time without any template being present, indicating a decrease in the pH of the paper. Through a series of leave-one-out experiments, it was determined that ammonium sulfate was responsible for this change (FIG. 21G).
  • FIG. 19C A schematic of the final device is shown in FIG. 19C and results from the device with and without heat-inactivated SARS-CoV-2 spiked into saliva at 5% reaction concentration are shown in FIG. 19D.
  • FIG. 19B the LoD of the assay on paper (250 copies/reaction) is comparable to the LoD observed in solution for the colorimetric RT-LAMP formulation (FIG. 211)
  • a Melinex® backing was used to provide structural support. Using a double-sided adhesive, two reaction pads were attached to the backing without altering their pH. The number of reaction zones can be arbitrarily increased to allow for multiplexed detection without altering the design of the device. 20 mil polystyrene spacers were added between reaction pads to provide a physical barrier inhibiting leakage from one reaction zone to an adjacent reaction zone, thus eliminating crosstalk during both reagent and sample addition. In some cases, the reaction zones can be separated by hydrophobic barriers resulting from wax printing preventing sample from crossing; however, to enable roll-to-roll manufacturing, wax usage was eliminated and spacers were used.
  • FIG. 21G shows that a 20 pL of RT-LAMP master mix containing a base formulation of KC1 (50 mM), MgSCh (8 mM), equimolar dNTP mixture (1.4 mM each dNTP), WarmStart BST 2.0 (0.32 U/pL), WarmStart RTx (0.3 U/pL), Phenol red (0.25 mM), dUTP (0.14 mM), Antarctic UDG (0.0004 U/pL), Tween 20 (1% v/v), (NHjftSCh (10 mM), and Trehalose (10% w/v) along with 5 pL of nuclease-free water was added Grade 1 chromatography paper and allowed to dry inside a PCR preparation hood for 10 minutes. Reactants were left out of the base formulation as indicated to determine the cause of the observed color change upon drying. RT-LAMP primers and templates were not included in this study.
  • FIG. 21B shows calibration of 250 pM phenol red at different pH values on paper buffered by 20mM Tris. pH values were adjusted using HC1 or KOH. The images of Grade 222 Chromatograph paper (5 mm x 6 mm) were cropped in the shape of a rectangle such that colors could be compared easily across multiple strips.
  • FIG. 21A shows RT-LAMP using orf7ab.I primer set and final formulation of colorimetric RT-LAMP master mix.
  • the left reaction zone on each device is the no primer control wherein all orf7ab.I primers were replaced with water and not included in the master mix.
  • the right reaction zone either contains heat-inactivated virus spiked into processed saliva at the indicated concentrations in the case of positive reactions, or processed saliva in the case of negative reactions. All processed saliva resulted in a final reaction concentration of 5%.
  • FIG. 21C shows a scatter plot of the colorimetric response of paper pads in at varying concentrations.
  • the green color intensity threshold is showed with reference line 121.
  • FIG. 22C shows colorimetric scans for limit of detection (LoD) of LAMP for 25uL reactions across different heating devices after 60 minutes of incubation at 65 °C.
  • the primer set used for these reactions was orflab.II.
  • 20 pL reaction mixtures were spiked with 5 pL of heat-inactivated virus dilutions in water to result in the final labeled concentrations (positive reactions) or nuclease-free water (negative).
  • Reaction master mixes included 12.5 pL of NEB Colorimetric 2x master mix, 2.5 pL of primer mix, and 5 pL of water.
  • FIG. 22D shows colorimetric scans after 60 minutes of incubation at 65 °C for 25pL reactions on the qTower (96-well plate) and thermocycler (PCR tubes) with varying ramp rates.
  • the primer set used was orflab.II. 20 pL.
  • Reaction mixtures were spiked with 5 pL of heat-inactivated virus dilutions in water to result in the final labeled concentrations (positive reactions) or nuclease-free water (negative).
  • Reaction master mixes included 12.5 pL of NEB Colorimetric 2x master mix, 2.5 pL of primer mix, and 5 pL of water.
  • FIG. 21H shows colorimetric RT-LAMP results with the inclusion of Trehalose or Tween 20 at the given concentration.
  • the orflab.II primer set was used. 20 pL of RT-LAMP master mix containing a base formulation of KCl (50 mM), MgSCh (8 mM), equimolar dNTP mixture (1.4 mM each dNTP), WarmStart BST 2.0 (0.32 U/pL), WarmStart RTx (0.3 U/pL), Phenol red (0.25 mM), dUTP (0.14 mM), Antarctic UDG (0.0004 U/pL), Tween 20 (1% v/v, if indicated).
  • a paper-based device to detect nucleic acids of pathogens of interest in complex samples can use loop-mediated isothermal amplification (LAMP) by producing a colorimetric response visible to the human eye.
  • LAMP loop-mediated isothermal amplification
  • the device detected SARS-CoV-2 in human saliva without preprocessing.
  • the resulting device was capable of detecting the virus within 60 minutes and had an analytical sensitivity of 97% and a specificity of 100% with a limit of detection of 200 genomic copies/pL of patient saliva using image analysis.
  • the device included a configurable number of reaction zones constructed of Grade 222 chromatography paper separated by 20 mil polystyrene spacers attached to a Melinex® backing via an ARclean® double-sided adhesive. The resulting device could detect multiple targets and a variety of pathogens by changing the LAMP primer sets.
  • the platform has the following properties: i) it uses saliva, ii) it has minimal operator training, iii) it can be fabricated using roll-to-roll methods to achieve millions of tests, iv) it performs similar to a RT-qPCR assay in terms of analytical sensitivity and specificity, v) it provides a colorimetric response visible to the naked eye, vi) it is amenable to point-of-care use, vii) it provides results in less than 60 minutes, and viii) it is estimated to cost ⁇ $10/test.
  • the platform can be readily reconfigured to target different pathogens by screening primer sets in solution. Multiplexing is enabled by adding additional reaction sites to the device. The reconfigurable nature of the platform allows it to be used for detection of emerging pathogens in future public health emergencies.
  • a method of testing for a presence of a target nucleotide sequence that can comprise: providing a biological sample; and dispensing the sample into a test environment having a solid phase reaction medium in combination with a loop-mediated isothermal amplification (LAMP) reagent mixture and a pH sensitive dye.
  • LAMP loop-mediated isothermal amplification
  • the biological sample is at least one of: saliva, mucus, blood, urine, sweat, exhaled breath condensate, or feces.
  • the method can further comprise collecting the biological sample using one or more of a saliva collection device, a nasal swab, a blood collection device, a urine collection device, a sweat collection device, an exhaled breath condensate collection device, or a stool collection device.
  • test environment can be substantially free of volatile reagents, pH-affecting reagents, drying agents, or combinations thereof.
  • the method can further comprise providing a solid phase reaction medium comprising cellulose or glass fiber.
  • the target nucleotide sequence can be from at least one of a viral pathogen, a bacterial pathogen, a fungal pathogen, or a protozoan pathogen.
  • the target nucleotide sequence can be from a viral pathogen.
  • the viral pathogen can be selected from the group consisting of: Coronoviridae, Orthomyxoviridae, Paramyxoviridae, Picomaviridae, Adenoviridae, and Parvoviridae.
  • the viral pathogen can be selected from the group consisting of: severe acute respiratory syndrome coronavirus (SARS-CoV-1), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome (MERS), influenza, and H1N1.
  • the method can further comprise providing an amount of reverse transcriptase sufficient to facilitate a reverse transcription LAMP (RT-LAMP) reaction.
  • the target nucleotide sequence can be from a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen.
  • SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
  • the method can further comprise raising a test environment temperature at a rate of about 0.1°C per second.
  • the method can further comprise providing a heating uniformity in the testing environment that has a variability of less than 1°C.
  • a biological sample testing apparatus that can comprise a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye, wherein the apparatus provides a degree of test accuracy of at least about 95% after storage for 6 months when stored at room temperature.
  • LAMP loop-mediated isothermal amplification
  • the apparatus can provide a degree of test accuracy of at least about 95% after storage for 12 months when stored at room temperature.
  • the apparatus can provide a degree of test accuracy of at least about 95% after storage for 2 years when stored at room temperature.
  • a biological sample testing system that can comprise: a substrate engaging a solid phase reaction medium in combination with a dehydrated loop-mediated isothermal amplification (LAMP) reagent mixture and a dehydrated pH-sensitive dye, said housing operable to receive a biological sample; and a heater configured to isothermally heat the container to an internal temperature sufficient to initiate and sustain a LAMP reaction between the LAMP reagent mixture and a biological sample for a time used to generate a test result via the pH-sensitive dye.
  • the substrate can comprise an optically transparent material.
  • the substrate can engage the solid phase reaction medium via an adhesive.
  • the adhesive in another example of a biological sample testing system, can be substantially optically transparent.
  • the substrate can comprise a portion of a housing.
  • the biological sample testing system can further comprise an adhesive layer disposed on the substrate; a reaction layer disposed on the adhesive layer; and a spreading layer disposed on the reaction layer.
  • the biological sample testing system can further comprise a spacer layer oriented in the same plane as the reaction layer.
  • the biological sample testing system can further comprise a housing disposed against the substrate.
  • the housing is further disposed against the spreading layer.
  • the housing can substantially enclose the substrate, adhesive layer, reaction layer, and spreading layer.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La présente divulgation concerne des ensembles de réaction d'amplification isotherme induite par boucle (LAMP, pour « loop-mediated isothermal amplification ») comprenant un mélange réactif LAMP exempt d'agent sensiblement hygroscopique en combinaison avec un milieu réactionnel en phase solide. La présente divulgation concerne également des systèmes pour une analyse LAMP chromatique comprenant un milieu réactionnel en phase solide sensiblement non réactif et un mélange réactif non interférant. La présente divulgation concerne également des milieux réactionnels LAMP en phase solide comprenant un substrat, une couche adhésive agencée sur le substrat, une couche de réaction agencée sur la couche adhésive et une couche de diffusion agencée sur la couche de réaction. La présente divulgation concerne également des procédés de test d'une présence d'une séquence nucléotidique cible comprenant la fourniture d'un échantillon biologique et la distribution de l'échantillon dans un environnement d'essai ayant un milieu réactionnel en phase solide en combinaison avec un mélange réactif LAMP, ainsi qu'un colorant sensible au pH.
PCT/US2022/012640 2021-01-15 2022-01-15 Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide WO2022155550A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP22704038.3A EP4278003A1 (fr) 2021-01-15 2022-01-15 Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163138321P 2021-01-15 2021-01-15
US63/138,321 2021-01-15

Publications (1)

Publication Number Publication Date
WO2022155550A1 true WO2022155550A1 (fr) 2022-07-21

Family

ID=81025318

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/012640 WO2022155550A1 (fr) 2021-01-15 2022-01-15 Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide

Country Status (4)

Country Link
EP (1) EP4278003A1 (fr)
AR (1) AR124664A1 (fr)
TW (1) TW202246524A (fr)
WO (1) WO2022155550A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017160836A1 (fr) * 2016-03-14 2017-09-21 Diassess Inc. Systèmes et procédés pour effectuer des tests biologiques
WO2020257356A2 (fr) * 2019-06-18 2020-12-24 Mammoth Biosciences, Inc. Dosages et méthodes de détection d'acides nucléiques
WO2021183921A1 (fr) * 2020-03-12 2021-09-16 New England Biolabs, Inc. Test de diagnostic rapide pour technique lampe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017160836A1 (fr) * 2016-03-14 2017-09-21 Diassess Inc. Systèmes et procédés pour effectuer des tests biologiques
WO2020257356A2 (fr) * 2019-06-18 2020-12-24 Mammoth Biosciences, Inc. Dosages et méthodes de détection d'acides nucléiques
WO2021183921A1 (fr) * 2020-03-12 2021-09-16 New England Biolabs, Inc. Test de diagnostic rapide pour technique lampe

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DAVIDSON JOSIAH LEVI ET AL: "A paper-based colorimetric molecular test for SARS-CoV-2 in saliva", BIOSENSORS AND BIOELECTRONICS: X, vol. 9, 1 December 2021 (2021-12-01), pages 100076, XP055911157, ISSN: 2590-1370, DOI: 10.1016/j.biosx.2021.100076 *
KELLNER MAX J. ET AL: "A rapid, highly sensitive and open-access SARS-CoV-2 detection assay for laboratory and home testing", BIORXIV, 23 June 2020 (2020-06-23), XP055911082, Retrieved from the Internet <URL:https://www.biorxiv.org/content/10.1101/2020.06.23.166397v1.full.pdf> [retrieved on 20220409], DOI: 10.1101/2020.06.23.166397 *
LABARRE PAUL ET AL: "Instrument-free nucleic acid amplification assays for global health settings", SENSING TECHNOLOGIES FOR GLOBAL HEALTH, MILITARY MEDICINE, DISASTER RESPONSE, AND ENVIRONMENTAL MONITORING; AND BIOMETRIC TECHNOLOGY FOR HUMAN IDENTIFICATION VIII, SPIE, 1000 20TH ST. BELLINGHAM WA 98225-6705 USA, vol. 8029, no. 1, 13 May 2011 (2011-05-13), pages 1 - 15, XP060014496, DOI: 10.1117/12.882868 *
SAFAVIEH MOHAMMADALI ET AL: "Emerging Loop-Mediated Isothermal Amplification-Based Microchip and Microdevice Technologies for Nucleic Acid Detection", ACS BIOMATERIALS SCIENCE & ENGINEERING, vol. 2, no. 3, 14 March 2016 (2016-03-14), US, pages 278 - 294, XP055872000, ISSN: 2373-9878, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425166/pdf/nihms824791.pdf> DOI: 10.1021/acsbiomaterials.5b00449 *
THOMPSON DORIAN ET AL: "Mini review: Recent progress in RT-LAMP enabled COVID-19 detection", SENSORS AND ACTUATORS REPORTS, 15 August 2020 (2020-08-15), XP055911165, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428436/pdf/main.pdf> [retrieved on 20220411] *

Also Published As

Publication number Publication date
AR124664A1 (es) 2023-04-19
TW202246524A (zh) 2022-12-01
EP4278003A1 (fr) 2023-11-22

Similar Documents

Publication Publication Date Title
Zhu et al. Bienzyme colorimetric detection of glucose with self-calibration based on tree-shaped paper strip
Bahadır et al. Applications of commercial biosensors in clinical, food, environmental, and biothreat/biowarfare analyses
Li et al. Double-layered microfluidic paper-based device with multiple colorimetric indicators for multiplexed detection of biomolecules
CN108745428B (zh) 一种多通道三维微流控纸芯片及其制备方法
KR101751205B1 (ko) 개선된 측방 유동 분석을 위한 단일 패드 스트립 및 이를 이용한 테스트 장치
CN110998324A (zh) 数字测定
EP3132049B1 (fr) Dispositif et procédés d&#39;utilisation du dispositif pour la détection d&#39;aminoacidopathies
Krishnan Colorimetric visual sensors for point-of-needs testing
Kim et al. Simultaneous quantification of multiple biomarkers on a self-calibrating microfluidic paper-based analytic device
Parween et al. An affordable, rapid determination of total lipid profile using paper-based microfluidic device
Feng et al. Simultaneous and sensitive detection of multiple small biological molecules by microfluidic paper-based analytical device integrated with zinc oxide nanorods
Tsai et al. Simultaneous determination of renal clinical analytes in serum using hydrolase-and oxidase-encapsulated optical array biosensors
WO2022151545A1 (fr) Procédé pour détecter un produit d&#39;amplification d&#39;acide nucléique multiple et kit de détection associé
WO2022155380A1 (fr) Méthodes, essais et systèmes de détection d&#39;un analyte cible
US20220235408A1 (en) Loop-mediated isothermal amplification (lamp) on a solid-phase medium
WO2022155550A1 (fr) Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide
AU2022208714A1 (en) Loop-mediated isothermal amplification (lamp) on a solid-phase medium
WO2022155549A1 (fr) Amplification isotherme induite par boucle (lamp) sur un milieu en phase solide
US11041860B2 (en) Point-of-care device for the colorimetric determination of hemoglobin and glucose-6-phosphate dehydrogenase in biological samples
CN117751196A (zh) 固相介质上的环介导等温扩增(lamp)
Kuo et al. Digital and Absolute Assays for Low Abundance Molecular Biomarkers
TR2023008289T2 (tr) Loop-mediated isothermal amplification (lamp) on a solid-phase medium
EP3404418A2 (fr) Bande de diagnostic permettant de déterminer la quantité de sarcosine, de créatinine et de peroxyde d&#39;hydrogène dans un échantillon biologique ou environnemental
Wicaksono et al. Cotton fiber-based assay with time-based microfluidic absorption sampling for point-of-care applications
US20230349008A1 (en) Paper-based sample testing devices and methods thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22704038

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022704038

Country of ref document: EP

Effective date: 20230816